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INTRODUCTION 
Some three years ago I availed myself of an opportunity of pursuing a re-
search project in the Department of Medicine at this Medical School. At that 
time, a long established interest in the study of plasma albumin metabolism was 
given fresh impetus by the development of techniques which overcame the problem 
of measuring rates of albumin synthesis and catabolism under conditions of meta-
bolic chonge. Interest in the Department had centred mainly upon the nature of 
the adaptive changes occurring in albumin metabolism in response to altered dietary 
protein intake, and by the time I was due to take up my appointment many of these 
adaptive changes had been clearly defined. The factors mediating these 
changes however remained unknown. 
The possibility that growth hormone was, at least in part, responsible for 
mediating these adaptations was suggested by reports of elevated levels of th is 
hormone in the plasma of children suffering from kwashiorkor. The elevated growth 
hormone levels were shown to correlate inversely with the degree of hypoalbuminaemia, 
and the fact that after thl'ee weeks of treatment when the albumin concentration had 
risen to normal levels, the plasma growth hormone was no longer elevated, suggested 
some form of relationship between albumin and growth hormone. When the literature 
was consulted, a considerable body of evidence was found which implicated the par-
ticipation of growth hormone in the regulation of albumin metabolism. All of these 
studies however had become dated by the development of newer concepts and tech-
niques and a reinvestigation of the role of growth hormone in albumin homeostasis 
appeared justified. Such a study forms the basis of this thesis, and sets out to answer 
the fol lowing questions: 
(i) Does growth hormone deficiency and growth hormone treatment result in any 
changes in albumin synthesis and catabolism, and if so what is the nature of 
these changes? 
{ii) Are the adaptive changes that occur in albumin metabolism under conditions 
of protein deprivation and repletion in any way explicable in terms of the 
actions of this hormone? 
To this end, and with techniques valid under non-steady metabolic conditions, 
albumin synthesis and catabolism was measured in hypophysectomised rats, and in hypo-
physectomised rats receiving growth hormone replacement therapy. 
CHAPTER ONE 
HISTORICAL BACKGROUND 
It was on the basis of c I in ical and pathological observations that the pitui-
tary gland was first suspected of participating in the regulation of body growth (1). 
Acromegaly, a condition characterised by the abnormal overgrowth of certain parts 
of the body, first described by Pierre Marie and attributed subsequently by Minkowski 
to hyperactivity of the pituitary gland, contrasted with a form of dwarfism first des-
cribed by Paltauf. The deduction that the pathogenesis of these clinical presentations 
was hypofunction or hyperfunction of the pituitary gland, was made essentially on the 
basis of the post mortem findings of 'atrophied' pituitary glands, or pituitary tumours. 
Such observations of course were far from actually demonstrating the presence of a 
growth promoting factor in the pituitary gland. 
More convincing evidence however, was provided in 1909 and later in 1912 
by Aschner (2 , 3 ) who, having performed the first successful experimental hypophy-
sectomy, demonstrated that surgical removal of the pituitary gland in young pups 
prevented their further growth and development. These findings on pups were soon 
confirmed by Crowe, Cushing and Homans (4) in 1910, and on tadpoles by Allen (5 ) 
and Smith (6) in 1916. Studies on the rat were initially less conclusive for some 
hypophysectomies resulted in abesity, whilst others caused the more familiar post-
operative "cachexia". The cause of this obesity, to which attention was first drawn 
by Aschner, (3 ) was the subject of considerable debate during the third decade of 
this century, and was centred mainly around the question as to whether the obesity 
resulted from the removal of the pituitary gland itself, or from concomitant hypo-
h I • · · (7 - 1 O) As • d' d · h 2 h ' I d . t a am1c in I ury. 1s 1scusse in c apter , t e issue was reso ve in 
1927 by Smith (l l' 12) who by devising an alternative operative technique con-
vincingly showed that this post-operative obesity was due to hypothalamic damage 
alone, and that as in dogs and tadpoles further growth and development was prevented 
by removing the anterior lobes of the pituitary gland, - findings soon confirmed by 
other workers. (l 3 - l 5) 
Additional evidence for growth controlling properties of the anterior pituitary 
gland was derived from studies in which simple anterior pituitary extracts were adminis-
tered to animals in order to obtain exaggerated growth responses. Evans and Long in 
(16) . 1921 were the first/ •.•••• 
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1921 (l 6) were the first to achieve success in such studies, producing giant rats by 
daily intraperitoneal injections of an ox pituitary extract. The production of 
acromegaly in dogs was subsequently reported by Putnam et al (l 7) and Evans et 
al (l 9) in 1929 and 1933 respectively. The rat and canine experiments of 
Smith, (ll, 12) Reichert (1 9) and Richter (1 3) between 1927 and 1930 provided the 
first demonstrations that growth could also be resumed after hypophysectomy if pituitary 
glands were administered as a replacement therapy. Proof of the existence of an an-
terior pituitary growth hormone finally came in 1944 with the isolation of the hormone 
in a highly purified form by Li. (20, 21 ) 
Earlier workers were quick to appreciate that these marked effects on growth 
and development must herald important consequences for protein metabolism. In 
1929 Teel and Watkins (22) observed in the dog that the fasting non protein nitrogen 
of the blood was lowered after the injection of a pituitary extract. Teel and Cushing 
(23 ) showed that such injections also caused a marked diminution of urinary nitrogen 
excretion and Gaebler (24 , 25) confirmed that this reduction in nitrogen excretion 
was almost entirely accounted for by a fall in urea excretion, a result verified by 
h . I . h h · (26 ) E · 1m some twenty years ater w 1t a pure ormone preparation. xperiments 
with rats provided similar information. Following the injection of simple pituitary 
extracts a fall in the fasting non-protein nitrogen of the blood, (27) plasma amino 
"d (28, 29) d . . (27, 30, 31 ) d d . b I ac1 s, an urinary nitrogen was reporte , an nitrogen a once 
studies revealed that pituitary extract administration enhanced the positive nitrogen 
balance shown by growing rats. (30) All these features were confirmed in 1948 by 
Li and Evans (32) using a highly purified growth hormone preparation. 
Taken collectively these findings were interpreted to mean that under the in-
fluence of growth hormone nitrogen was being retained in the tissues in the form of 
protein, and was confirmed by studies of the chemical composition of body tissues. 
Lee and Schaffer (30) studied treated and growth hormone treated rats in which the 
food intake was kept equal in both groups. The treated rats gained more weight and 
had a larger positive nitrogen balance than the untreated rats. Carcass analysis at 
the end of the experimental period showed that the nitrogen content of the treated 
rats on a percentage basis exceeded that of the controls. In a group of treated rats 
allowed to eat ad/ .•........ 
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a I lowed to eat ad I ibitum, the features were even more pronounced. Similar findings were also 
reported by Young (33 ) and Li and Evans, (32 ) and contrasted markedly with the 
situation in hypophysectomised animals in which increased urinary nitrogen excre-
tion, (34) increased blood levels of urea (35) and decreased protein content of the 
carcass (36 ' 37) were reported. 
. (38) By the tum of the half century, as both isotopes and growth hormone 
became increasingly available for research purposes, more attention was being paid 
to the dynamic effects of growth hormone on protein metabolism. The past twenty 
years have witnessed intensive investigation in this field so that any sensible survey 
of the subject, even were it within the scope of this thesis, would be a formidable 
undertaking. Thus, having attempted to place the earlier work relating to growth 
hormone and protein metabolism in some historical perspective, an opportune point 
is reached where attention can be focussed on the particular protein chosen for 
study in this thesis, that of plasma albumin. 
The first indication that the anterior pituitary gland might play a role in 
albumin homeostasis was presented in 1938 by Goldberg, (39) who observed that the 
plasma albumin level was moderately reduced in hypophysectomised dogs. That 
finding has been confirmed in the dog and in other species in a number of subsequent 
studies. In a series of investigations in the rot, Levin and co-workers observed that 
the serum albumin concentration three weeks after hypophysectomy, was 25.5%, (40) 
23.4% (4 l) and 26.1% (42 ) less than the values obtained in normal rots, whilst a 
29% decrease was reported by Leathern (43 ) after the same time interval. Similar 
observations were mode by Li. After a two week post-operative interval, reductions 
of 22% (44) and 21.3% (45) from control values were noted. Bernasconi (46) showed 
that the serum albumin concentration had fallen by 27% of its pre-operative value 
within five days after hypophysectomy, and that no further significant reduction 
occurred over the next fifteen days. 
Although Pedersen and Carstensen (47) observed only slightly reduced albumin 
levels in hypophysectomised rabbits and concluded that it was "unlikely that the 
pituitary played a predominant role in plasma protein regulation", further investigation 
did not appear/ •....•••.•..• 
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did not appear to justify this contention. Thus a 22% fall in aJbumin concentration 
was recorded in hypophysectomised dogs by Baker and Mi Iler, (4B) and Warner et 
al (49) observed in one of their dogs that a 27% fall occurred within five days of 
the operation and that no further fol I occurred over the next nine weeks. 
These studies, in which albumin levels were observed to fall by approximately 
25% from control values within two weeks after hypophysectomy, seemed to offer 
convincing evidence for implicating the pituitary gland in albumin homeostasis, but 
it remained to be es tab I ished that the reduction in concentration had not resulted 
from some disturbance of the plasma volume. Further investigation provided evidence 
to suggest that th is was in fact not the case. 
In the rat, Enerback et al (50) demonstrated that the intravascular pool of 
combined albumin and c,( 1 globulin had decreased by 24% six to nine days after 
hypophysectomy, and Ulrich et al (5 l) showed that the "exchangeable" albumin 
(i.e. the sum of the intravascular and extravascular albumin pools) in the rat was 
reduced two weeks after hypophysectomy. In a study of human hypopituitary subjects, 
Jeejeebhoy et al (52) observed that whereas only one of the four cases investigated 
had a lowered plasma albumin concentration, three had values for "total exchangeable" 
albumin that were slightly below the normal range. 
It was of course impossible to know from these studies if alterations in albumin 
synthesis or catabolism were responsible for the hypoalbuminaemia, and, if they were, 
what their nature was. There remains to this day strikingly little information on this 
aspect. From a review of the I iterature only two attempts appear to have been made 
to define the changes in albumin synthesis or catabol ism after hypophysectomy. De-
ferring a more detailed discussion of these studies to chapter five, it suffices here to 
merely record the results obtained, 
From the behaviour of a tracer dose of 35s label led albumin in hypophysectomised 
rats, Ulrich et al (5 l) concluded that after hypophysectomy a reduction in albumin 
synthesis occurred initially, followed by a reduction in catabolism. In the study on 
hypopituitary subjects referred to above (52) 131 I label led albumin was used as the 
tracer and in four/ •..•••..•.• 
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tracer and in four subjects three had rates of albumin catabol ism and "synthesis 
plus transfer" that were either at, or slightly below, the lower I imit of normal. 
Hypophysectomy producing as it did a multihormonal deficiency state, it 
remained to be ascertained which hormonal deficiency or deficiencies were re-
sponsible for the disturbances in albumin metabolism seen after hypophysectomy. 
The belief that growth hormone might at least be partially responsible for these 
observations was justified on the basis of the evidence cited earlier in this chapter 
in relation to its effects on overall protein metabolism, and led to studies of the 
effect of growth hormone treatment on albumin metabolism in particular, both in 
the intact state and as a replacement therapy after hypophysectomy. 
In the intact dog Campbell et al (53 ) found that administration of growth 
hormone for seven days produced a fall in the plasma albumin concentration but 
an increase in the intravascular pool size. In the intact rat Hoch-Ligeti and 
Irvine (54) observed no change in albumin concentration after a single large dose 
of growth hormone, and only small increases were observed by Bernasconi 
after a ten to twenty day period of treatment. 
(55) 
The first study in which growth hormone was used as a replacement therapy 
after hypophysectomy was that of Li and Reinhardt (45) in which the daily ad min is-
tration of the purified hormone over two weeks was shown to increase the albumin 
concentration to a level approximately halfway between the normal control value 
and the value obtained in untreated hypophysectomised rats. Warner et al (49) 
however were unable to show any effect of growth hormone on the hypoalbuminaemia 
of hypophysectomised dogs after two weeks of treatment. Enerback (50) demon-
strated in hypophysectomised rats that whi 1st nine days of hormone treatment had no 
effect on the low albumin concentration, the intravascular pool of albumin remained 
within the normal range. 
Studies designed to define the action of growth hormone in relation to al-
bumin metabolism have led to conflicting results, and again it suffices merely to 
record these varying results, deferring a more detailed discussion to a later chapter. 
Firstly in intact/ ..•.• , .•... 
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Firstly in intact animals, Bartlett and Gaebler (5B) concluded that growth hormone 
I d lb · h · · 
15N I · · d · lb • stimu ate a umin synt esrs since more g ycine was incorporate into a umin 
in dogs treated with growth hormone than in untreated controls. Using 131 1 label led 
albumin, Gross et al (56) observed no effects of growth hormone treatment on albumin 
synthesis or catabol ism, and concluded that the increase in plasma albumin concen-
tration that was demonstrated was due to reduced capillary permeability which re-
stricted the transfer of albumin from the intravascular to the extravascular compart-
ments. In a clinical study of four adult males, Gabuzda et al (57) showed that 
growth hormone administration reduced albumin catabolism but had no effect on al-
bumin synthesis. 
Equally varying results were obtained in studies where growth hormone was 
replaced after hypophysectomy, for in rats growth hormone was shown to stimulate 
albumin synthesis, (5 l) but rates of catabolism and "synthesis plus transfer" already 
low in hypophysectomised humans, were further lowered on growth hormone treat-
ment. (52) A final study that requires to be mentioned is that of Sellers et al (59) 
who measured albumin synthesis in the isolated perfused rat liver by the 14c carbonate 
method, and found a 33% increase in synthesis rate if the donor animal was pre-
treated with growth hormone. 
We have thus seen that what little information is available on the effects of 
growth hormone deficiency and treatment on albumin metabolism is conflicting in 
nature. To a great extent th is reflects the shortcomings of the methods used in the 
investigations, as will be discussed later. Relatively recent technical advances now 
permit more meaningful investigations of albumin metabolism, and a reinvestigation of 
the effects of hypophysectomy and growth hormone replacement therapy with these 
newer techniques forms the basis of this thesis. 
- 8 -
CHAPTER TWO 
A GENERAL ACCOUNT OF 
THE PRINCIPAL METHODS EMPLOYED IN THIS THESIS 
l. HYPOPHYSECTOMY: 
In the rat hypophysectomy is most easily performed via the parapharyngeal 
approach. The transbuccal approach described by Aschner in 1909 (2) and 1912 (3) 
is suitable for use in dogs, but for anatomical reasons is not feasible in the rat. A 
method employing a temporal approach was highly favoured in the third decade of 
this century and was used on dogs and rats but did not prove to be entirely satisfactory. 
As used in the rat, the temporal lobe of the brain is I ifted to expose the carotid artery, 
occulomotor nerve, hypothalamus and pituitary stalk. A fine hypodermic needle is 
inserted through the diaphragma sellae, and 0.01 ml. of a 5% solution of chromic 
acid injected into the gland. This method gave inconstant results due to incomplete 
ablation or to hypothalamic damage, the latter, as was mentioned in chapter one, 
often resulting in gross obesity. Its high mortality and morbidity and poor results, 
led Smith to devise the parapharyngeal technique which is described in detail in his 
monumental work of 1930. (l 2) This method is highly satisfactory and although it 
has been modified slightly, in essence forms the basis of the method universally em-
ployed today. Th is modified method is described by Ingle et al, (60) and has pro-
vided, with all but a few further modifications, the basis of the technique employed 
in this thesis. 
The method of transauricular hypophysectomy first described in 1931 by 
Koyama (6 l) has received scant attention. This method provides for the aspiration 
of the gland by means of a hypodermic needle and syringe passed through the wall of 
the external auditory meatus to I ie in the pituitary fossa. Major disadvantages of 
this technique are incomplete aspiration, especially in large rats, damage to the 
blood vessels at the base of the brain and secondary bacterial infection. In order 
to overcome these disadvantages Falconi and Rossi (62) have designed special needles 
sized according to the weights of the experimental animals, while Gay (63 ) has 
adapted the ear bars of standard stereotaxic frames to act as a guide to the needle, the 
proper angle of entry thereby being determined not by the skill of the operator, but by 
the design of the/ •.....•••.•• 
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the design of the apparatus. Neither modifications however seem likely to displace 
the parapharyngeal method as the method of choice. A detailed illustrated account 
of the parapharyngeal technique of hypophysectomy as employed in this thesis, is 
contained in the appendix. 
II. IODINATION: 
For the valid use of tracer molecules in metabolic studies, the fundamental 
requirement that needs to be satisfied is that the introduction of the label into the 
molecule must be achieved in such a fashion that the body fails to distinguish meta-
bolically between the tracer molecules and its own unlabelled molecules. Intensive 
research has led to a greater standardization of the conditions under which albumin 
may be label led reliably. Damage to label led albumin molecules may occur during 
any of the successive stages in their preparation, and it seems a convenient approach 
to consider these in turn. 
(a) Extraction of albumin from Plasma 
The susceptibility of albumin to damage from pH values of less than 4 or 
greater than l 0, and to contact with organic solvents (641 65) places some restric-
tions on the choice of fractionating methods. Whilst Korner and Debro (66 ) believe 
that the albumin obtained from their extraction process with TCA-ethanol is native 
albumin, the low pH (pH 1-2) to which the albumin is exposed, seems to preclude the 
use of this method. For this reason the same would seem to apply to the HCL-ethanol 
method, (67) though the experience of Sutherland (6S) indicates that albumin prepared 
by this method is not denatured. Salt precipitation, as for example with ammonium 
sulphate, (69) no matter how often repeated, appears to be a safe method of fractionation. 
Despite the fact that a percentage of globulins contaminate the albumin fraction thus ob-
tained, after labelling these contaminants can be reduced to insignificant levels by 
adding unlabelled plasma and repeating the precipitation procedure. (64) 
(b) Iodination 
Detailed reviews of the chemistry of iodination have been presented by Hughes 
(70' 71 ) d H I k t I (72 ' 73 ) 0 I · I b I f b an e m amp e a • n y cationic iodine is avai a e or su sti-
tution into the benzene ring of tyrosine. This may be formed from iodide with oxidising 
agents such as / ...........•... 
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. . (74) 
agents such as hydrogen peroxide or chloramine T. Whilst the chloramme T method 
has been used with success for the labelling of polypeptide hormones, oxidising agents 
appear to be injurious to plasma protein molecules and should therefore be avoided. (65) 
Suitable alternative methods rely on the formation of hypoidous acid (HOl) in 
aqueous solution as an essential prerequisite for labelling. Iodide-iodate methods (651 
75) which yield HOl have a theoretical efficiency of labelling of 50%, but if iodine 
monochloride (76 ) is used to yield HOl, the efficiency of labelling is theoretically 100%. 
The stability of the iodine monochloride solution, as well as the simplicity of the method 
as a whole, has led to its widespread use. 
At alkaline pH iodine monochloride in aqueous solution yields HOl. Exchange 
between radioiodine and HOl yields H0
131 1, and protein labelling proceeds with 
rapidity once this solution is introduced into the protein solution. Rapid mixing of 
these two solutions is necessary to obtain uniform labelling, but in the light of ex-
perience that has shown increased efficiency of iodination, (64) and reduced possi-
bilities for protein denaturation (65) if the volumes of the reactants is kept small, the 
elaborate counter-current jetting apparatus devised by McFarlane (65) has been dis-
pensed with. The iodine monochloride method has been scrutinised by Helmkamp et al 
(72 , 73 ) and the conditions for maximum efficiency of labelling have been clearly de-
fined. 
(c) Removal of radioiodide 
Whilst the theoretical efficiency of the iodine monochloride method is 100%, 
in practice efficiencies of 60 - 70% are achieved. Residual free radioiodide may be 
effectively removed by passage through a chloride ion exchange resin. Though the 
possibility of some surface denaturation cannot be excluded, (65) the preliminary 
addition of plasma to the column will minimise this risk. When however proteins are 
being labelled for turnover studies, for which standards of protein preparation may not 
be compromised, removal of radioiodide is best performed by dialysis against distilled 
water. 
(d) Self irradiation/ ..... . 
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(d) Self irradiation damage 
Albumin which has been subjected to radiation has evidenced abnormal 
chromatographic (77, 79) and metabolic (79) behaviour. Whilst adequate protection 
from self irradiation damage may be achieved by the addition of unlabelled carrier 
protein, (77) as a rule preparations should be put to use as soon as possible after 
labelling. 
(e) Sterilisation 
H ·1· . f lb · · · 'bl (90) eat steri 1sat1on o a umm 1s not perm1ss1 e. Seitz filtration and 
other filters operated by suction have been widely used, but suffer from the disad-
vantages that much of the sample may be retained in the filter bed despite washing 
through, and that excessive frothing may be deleterious to the protein preparation. 
Both of these objections are easily overcome by the use of 11 millipore 11 filter units. 
Proof of the satisfactory biological nature of the label led preparation imp I ies 
a comparison with the unlabelled protein, which as Hughes has remarked, (7l) is 
"obviously a circuitous proposition". It is clear that grossly misleading results could 
be obtained from the use of unsatisfactory albumin preparations. Whilst damage to 
grossly overiodinated albumin molecules may be detected by changes in absorption 
spectra and water solubility, (70) and in electrophoretic mobility, (9 l) molecules 
suffering lesser degrees of damage whether due to lesser degrees of substitution ( a 
mean of l atom iodine per molecule is the accepted safe level of substitution for 
albumin), or to any of the other possibilities outlined above, may show no abnormal 
physiochemical properties but behave abnormally II in vivo", (77, 82 - 84) 
11 In vivo" the most reliable test of iodine label led albumin consists of a com-
parison of its plasma half life with that of biosynthetically labelled 14c albumin. 
Rapid respiratory and renal excretion of 14c reduces reutilisation of this label to a 
negligible extent, and good agreement between the "in vivo" behaviour of iodine 
and 14c labelled albumin has been obtained in rats (95) and rabbits. (65 , 86 , 87) 
This approach has not only made it possible to define the normal range of turnover 
values for these/ ......... . 
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values for these species, but has also secured a place for iodine as a valid tracer 
substance, provided the various precautions mentioned above are taken when pre-
paring the labelled molecule. 
Comparison with a 14c labelled albumin preparation as a routine check on 
iodine label led preparations would hardly seem justified in view of the time and ex-
pense involved. Since damage to albumin molecules always results in more rapid 
but never slower rates of elimination (881 89) an abnormally high percentage of 
radioiodide in the urine, or retained in the plasma on the first day or two of the 
experiment, would provide alternative evidence of protein damage. With the pro-
viso that breakdown products are not retained in the body water, in cases of severe 
damage a short I ived rapid component may also be detected in the total body activity 
graph. It must be emphasised that minimal damage may manifest as nothing more 
than slightly increased rates of catabol ism. 
As wil I be evident from the description contained in Chapter 3 and in the 
appendix, the methods employed in this thesis were based on the principles outlined 
above, al I possible precautions being taken to ensure a satisfactory labelled albumin 
preparation. The final test remained as its behaviour "in vivo". Albumin turnover 
and plasma half lives were measured in a large group of normal rats, and the values 
thus obtained agreed well with those observed by other workers (Chapter 4). When 
turnover measurements were to be made under experimental conditions, the experi-
ments were designed so that turnover was first measured during a normal pre-operative 
control period. It was always established that these pre-operative turnover rates 
fel I into the normal range before embarking on the experimental procedures. In this 
way it was possible to be certain that any subsequent slowing of catabol ism that might 
be observed during the experimental period was not due to the completed excretion of 
more rapidly eliminated denatured molecules. 
Ill MEASUREMENT OF ALBUMIN CATABOLISM 
Many earlier estimates of albumin turnover were made with biosynthetically 
produced tracers. Biosynthetic labelling was achieved by the intravenous admini-
stration of 14c / ................. . 
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stration of 14c or 35s labelled amino acids which were then utilised by the liver 
for albumin synthesis. Since the incorporation of the label into the albumin molecule 
occurred "in vivo" there could be little doubt that the label was native. Despite this, 
values for albumin turnover and plasma half lives varied considerably. These dis-
crepancies were correctly attributed to reutilisation of the label. 
After the administration of a labelled amino acid, plasma proteins and proteins 
of al I body tissues become label led. As turnover continues and these tissues are broken 
down, the label re-enters the free amino acid pool and once again becomes available 
for albumin synthesis, thereby prolonging the observed plasma half life. Pen et al (90) 
showed convincingly that the degree of reutilisation was greatly influenced by the 
choice of labelled amino acid. Essential amino acids being more efficiently conserved 
displayed a high degree of reutilisation and hence longer plasma half lives than non 
essential amino acids. 
Reutilisation could be greatly reduced, and in the case of 14c proteins to 
negligible levels, if after the administration of the labelled amino acid, the albumin 
thus produced was isolated and transferred to another animal. This procedure first 
employed by Hevesy and Hahn in their work on phospholipids, is described in full by 
Goldsworthy and Volwiler. (9l) Unfortunately since only a small percentage of the 
injected amino acid becomes incorporated into albumin the technique is wasteful and 
becomes expensive if a sufficient yield is to be obtained. To do this the labelled amino 
acid must be administered in large doses, which whilst permissible for experimental 
animals, is precluded in humans because of the radiation risk involved. 
The use of iodine as a tracer label has much to commend it. In the first in-
stance, provided that the thyroid gland is 11 blocked 11 by the administration of inactive 
iodide, reutilisation of the label does not occur. (861 82) Secondly, the label is 
rapidly and quantitatively excreted in the urine, providing the means whereby cata-
bolism may be measured by a relatively simple method based on urinary excretion 
data not possible with biosynthetical ly produced tracers. Additional advantages re-
side in the relative simplicity of the techniques with which iodine may be tagged to 
albumin "in vitro", and the ease with which biological samples may be assayed for 
radioactivity. 
It is relevant at this/ •...•... 
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It is relevant at this point, before describing the methods by which albumin 
catabolism is measured, to consider briefly the fate of a tracer dose of albumin after 
its introduction into the blood stream. Immediately after intravenous injection, the 
dose rapidly becomes spread throughout the intravascular space. It may be assumed 
that within the ~irst few minutes after injection, no significant loss of labelled mole-
cules occurs into the extravascular spaces, so that the extent to which the dose is 
diluted will provide a measure of the size of the plasma volume. Almost immediately 
thereafter plasma radioactivities will be observed to diminish. If these radioactivities 
are plotted on semilogarithmic paper, the initial portion of the graph will be observed 
to consist of a curve which after a variable time resolves itself into a straight line, 
Fig. 2:1. The fall in the initial curved portion of the graph * results from the simul-
taneous onset of two processes: 
(i) loss of labelled molecules into the extravoscular spaces and 
(ii) catabolism. 
The final linear component reflects catabolism alone, but whilst the slope of this 
component provides an index of catabolism, for reasons to be discussed below, this 
slope alone is insufficient for actual quantitation of the catabol ic rate. 
Transfer of labelled molecules from intravascular to extravascular compart-
ments results in albumin being widely distributed throughout the body (in lymph 
channels, serous cavities, cerebrospinal fluid etc.) from which return occurs via 
the main lymph channels in the thorax, so that under steady conditions the amount 
of albumin passing from intravascular to extravascular compartments is balanced by 
an equal amount returning in the opposite direction. Despite its widespread distri-
bution, it has been established that albumin is only catabol ised in relation to the 
intravascular compartment. Evidence suggesting intravascular catabol ism was first 
provided by Berson and Yalow (92) who observed that the daily urinary excretion 
of the label was a constant fraction of the activity remaining in the plasma over that 
same period, but bore no relation to the concentration of the label in the extra-
vascular compartment/ .•••... 
* The curved portion of the graph, occurs when there is a net flow of labelled 
molecules from the intravascular to extravascular compartments. This lasts for a 
variable period of time usually not less than 48 hours, and is frequently referred 
to as the Distribution Period. 
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vascular compartment or whole body. 
(85) (89 93) 
Campbel I et al and McFarlane ' 
confirmed this observation and it became accepted that catabolism occurred intra-
vascularly, or at least in tissues in close metabolic proximity. In such a situation 
it will be clear that specific activity differences must exist between the intravascular 
and extravascular compartments. There will always be a net transfer of labelled 
molecules from the extravascular to intravascular compartments where they are cata-
bolised. Since albumin of higher specific activity continually enters the intravascular 
compartment from the extravascular compartment, the plasma half I ife wi 11 be prolonged 
and will underestimate the true rate of decline of intravascular activities, and the 
metabolic rate. 
Methods for the calculation of the albumin catabolic rate fall broadly into two 
main categories. The first category contains a group of methods which are based on 
the analysis of plasma radioactivities alone. The second category makes use of both 
urinary and plasma radioactivities for the purpose of calculation. 
Category 1: The first measurement of albumin catabol ism in man was carried 
out by Sterling (94) and was based on the behaviour of the terminal exponential part 
of the plasma radioactivity curve. Data thus obtained would only acquire validity 
in the event of catabolism occurring at equal rates in both intravascular and extra-
compartments, since this method assumes that specific activities in both compartments 
are equal at all times. From the evidence cited above, such a situation clearly does 
not obtain. 
In its simplest form, the model describing the synthesis, catabolsim and distri-
bution of albumin is a two compartment open mamil lary system, (Fig. 2:2). The intra-
vascular compartment to which albumin is added by liver synthesis and from which 
losses due to catabolism occur, exchanges reversibly with a single extravascular com-
partment. The mathematical equations describing this situation were first presented 
by Rescigno, (95) and the information required for their solution was obtained by 
graphic analysis of the plasma radioactivity curve. (75) In most instances the plasma 
curve resolved into two first order components and was described by the equation:-
X = I .................... . 
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+ 
where x = isotope concentration in plasma at time t 
where c 1 and c2 = the y axis intercepts of the two components 
where b1 and b2 = the slopes of the two components 
from which the following expression for the calculation of the fractional catabolic 
rate was derived:-
It can be seen from this expression that information from both components 
of the graph is required for the calculation of the fractional catabol ic rate and 
serves to emphasise the inappropriateness of the Sterling model based on the ter-
minal exporential alone. As increasingly complex kinetic models have been pro-
posed (75 , 96 - 99) plasma radioactivity curves have been subjected to more and 
more sophisticated forms of analysis often requiring the aid of analogue computers. 
McFarlane (64) has referred to some of the difficulties of this form of analysis, 
which in addition, in non steady states becomes exceedingly complex. {lOO) 
Category 2: The use of urinary radioiodide excretion data makes it 
possible to calculate the catabol ic rate under both steady and non steady states 
with relative ease. As albumin molecules are catabolised, the released iodide 
accumulates in the body water until the renal iodide threshold is reached, and 
since the urinary route is for practical purposes the sole route of iodide excretion, 
the amount appearing in the urine wi II provide a quantitative estimate of the 
amount of albumin catabolised. Although iodide (the principal form in which the 
label is liberated after catabolism) is concentrated and secreted in salivary gland 
and gastro-intestinal secretions, it is extensively resorbed in the gut and the amount 
of iodide excreted in the faeces may be neglected under normal circumstances. 
This method (frequently referred to as the Clearance Method), was first used by 
~2 ~) . Berson and Yalow ' and has the advantage that the catabol ,c rate may be 
calculated on a daily basis, thus enabling shortlived fluctuations to be detected. 
The daily fractional/ ••• , . 
ks 
' 
I k1 
I.V. P. I 
<: 
'; 
::> 
I E.V. P. 
k2 
y 
I.V.P. = lntravascularpool, E.V.P. = Extravascularpool. 
ks = rate constant for albumin synthesis, kc = rote constant 
for albumin catabolism, k1 and k2 = rote constants for trans-
fer from 1.V.P. to E.V.P., and E.V.P. to I.V.P. respectively. 
- 19 -
The daily fractional catabolic rate (as percentage of the intravascular pool) is that 
fraction of the protein bound activity in the plasma that is excreted daily in the urine. 
Knowing the size of the intravascular pool of albumin, an estimate of the absolute 
amount of albumin catabol ised can be obtained. (B9) 
The absolute catabolic rate may also be calculated under non steady conditions 
in which the intravascular pool is changing, by expressing the plasma data as albumin 
specific activities. This method is valid under non steady states since the only assump-
tion made is that the specific activity of albumin in the plasma is the same as that at 
the sites of catabol ism. (l Ol) 
Extrovascular albumin 
The presence of a large mass of extravascular albumin has implications for 
both biophysicist and clinician alike. Its subdivisions and the rates of exchange 
with the intravascular compartment are of importance to the kineticist interested 
in providing the most representative model of albumin metabolism, whilst estimation 
of its size is of importance to the clinician since in disease states when abnormal 
losses of albumin occur from the intravascular compartment, albumin is transferred 
from the extravascular compartment to the intravascular compartment in an attempt 
to mitigate these losses. Methods of measuring the extravascular pool of albumin 
have been reviewed by Schultze and Heremans. (l 02) 
MEASUREMENT OF ALBUMIN SYNTHESIS 
The direct measurement of the rate at which a protein is synthesised can be 
achieved by measuring the rate at which a labelled precursor amino acid is incor-
porated into that protein. Since iodine is never used for protein synthesis, amino 
acids bearing this label can never provide direct information about rates of protein 
synthesis. Albumin synthesis rates have frequently been inferred from the "in vivo" 
behaviour of tracer doses of iodinated albumin. Under steady state conditions it 
is permissible to infer the synthesis rate after a measurement of the catabolic rate, 
since obviously under these conditions the two processes proceed at the same rate. 
Under non/ ••.. , .....•.••• 
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Under non steady state conditions however this simple expedient is no longer possible, 
and various methods of analysis have been proposed in attempts to determine the 
separate contribution of synthetic and catabolic processes to observed radioactivities. 
The major obstacle to the direct measurement of plasma protein synthesis rates, 
is the need for accurate measurement of precursor amino acid specific activities. 
Since these specific activities are those at the intracellular site of protein synthesis, 
and not of the amino acid as it circulates in the blood stream, it is necessary to ob-
tain tissue samples for measurement. In the case of albumin, specific activities 
would have to be made on biopsy samples of liver tissue. Furthermore since after 
the ad min is trot ion of a single dose of label led amino acid, precursor specific ac-
tivities may display considerable fluctuation, repeated biopsy samples would be 
necessary in order to define the precursor specific activity curve. In the face of 
these difficulties many investigators have been obliged to rely on various indirect 
methods of measuring albumin synthesis, to which attention will be drawn at the end 
of th is chapter. 
Yet it is possible to overcome this seemingly insoluble problem of sampling 
by the use of external indicators of intracellular precursor specific activities. This 
approach based on the precursor-product relationship will be discussed further in a 
later paragraph. In respect of albumin production, urinary hippuric acid has been 
d I ' d' f · h · I · 'f· · · (l o3 ) d propose as an externa in 1cator o intra epat1c g ycine spec, 1c act1v1ty an 
urea (l 04) has been proposed as an external indicator of intracellular arginine 
gus:midine carbon specific activity. Recently the technique for measuring albumin 
synthesis by comparing the rates of incorporation of cystine and cysteine into albumin 
with the rates that these two amino acids ore oxidised into inorganic sulphate has been 
• d O 34) d · 1 1 14co f 14c b · f · h 1 revive , an arteria tote 2 a ter car onate in us1on as recent y 
been suggested as an alternative to urea as an external indicator of in trace I lular 
. . 'f' . . (135) arginine spec1 1c act1v1ty. 
The proposal to use urea as an external indicator of intracellular specific 
activity arose out of the earlier work of Delluva and Wilson (l 05) who demonstrated 
that after its administration, 14co2 condensed with ammonia to give by way of 
intermediates in the/ •...•.• 
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intermediates in the Krebs-Henseleit cycle, arginine that is labelled only at the 
guonidine carbon position (Fig. 2:3). Arginine may then be used for albumin syn-
thesis (l04 ) or the guanidine carbon may be split off by the action of arginase to 
provide the single urea carbon atom. Since the production of urea from arginine 
is many times greater than the protein produced from this source, and since urea 
rapidly leaves the hepatic cells, urea may be regarded as a reliable external in-
dicator of intracellular arginine guanidine carbon specific activities. (64) 
In 1963 Mcfarlane (69) and Reeve et al (l 06) separately reported a method 
for the direct measurement of albumin synthesis (and other proteins produced solely 
by the liver) which by exploiting this metabolic relationship between the guanidine 
carbon of free intracellular hepatic arginine and albumin arginine, and of urea 
carbon, obviated the need for measuring intracellular specific activities. 
In general terms, if P is the mean precursor specific activity ( }'c/g) through-
out a given time interval during which a product containing M grams of precursor 
and R pc is produced, then R = MP and rearranging P = ! . Furthermore th is re-
lationship holds good (vide infra) for al I products of the same precursor, so that 
p = R = 
M 
= = 
R 
ooeioo•o••••• n 
M 
n 
More specifically for the case of albumin, since albumin arginine guanidine carbon 
and urea carbon are the two products of a single precursor namely, intracellular 
arginine guanidine carbon, then 
R albumin 
M albumin = R urea . . ( ) (l ) M , at a given time t urea ------------------
where M albumin = mass of albumin guan idine carbon synthesised 
M urea = mass of urea carbon synthesised 
R albumin = total activity in albumin guanidine carbon 
R urea = total activity in urea carbon 
The validity of this precursor product relationship, which states that the ratio 
of mass to radioactivity in products of the same precursor is constant, has been demon-
strated in mathematical terms by Reeve et al (l 06) and Reeve. (l O?) 
Since the tota I / ........... . 
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Since the total activity appearing in each of these two products in a given 
time will be proportional to their absolute (mass) rates of formation, it is possible 
to deduce the absolute rate of albumin synthesis if the total activity incorporated 
into the two products, and the absolute rate of urea synthesis are known. Diffi-
culties have however been encountered in the accurate measurement of the absolute 
rate of urea synthesis. In view of endogenous catabolism of urea by bacterial action 
in the gut, the amount of urea excreted is considerably less than that synthesised (l OS, 
109) and it is not possible as has been suggested (69) to infer the absolute rate of urea 
synthesis from the mass of urea excreted. Koj et al (l l O) suggested that the mass 
rate of urea synthesis could be obtained from the product of the fractional rate of 
urea synthesis and the body urea pool. As was shown by Regoeczi et al (l 09) un-
certainty exists about the accuracy of measurements of the size of the body urea 
pool by any of the available methods, since estimates based on a 14c urea dilution 
technique differed from those based on body water measurements. The latter 
method in addition assumes that urea is present throughout the body water at the 
same concentration as in the plasma, which in that study at least was not shown to 
be the case. 
In the light of these difficulties a modified formula has been proposed by 
McFarlane (l l l) in which total activities are substituted for by specific activities 
(S.A.) and which provides for the determination of fractional rates instead of mass 
rates of synthesis. In this way the need for measuring the body urea pool is dis-
pensed with. 
Rearranging equation (l) 
M alb. 
M urea = 
R alb. at t 
R urea at t 
By arbitrarily dividing both sides of the equation by the sizes of the urea carbon 
and guan idine carbon pools, the following working formula is derived: 
and by rearranging 
FSR alb. 
FSR urea 
FSR alb = 
= 
SA alb. att 
SA urea at t 
FSR urea x SA alb, at t 
SA urea at t 
------
where FSR = fractional synthesis rate 
(2) 
Th is relationship/ , ..•.•..•• 
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This relationship will only be true if the system is closed. Since however losses of 
both urea and albumin occur from the intravascular compartment, observed specific 
activities at time 't' have to be corrected to obtain values that would have existed 
had no such losses occurred. The assumptions and workings of the method by which 
albumin is measured directly will now be discussed in general terms. 
14c carbon guanidine arginine may be introduced into the liver by either 
administering the labelled amino acid as such, or by administering 14c sodium car-
bonate from which 14co2 is I iberated and incorporated into arginine via the urea 
cycle. These two approaches have been evaluated by Mcfarlane, (69) who has 
shown that the use of the 14c carbonate label is to be preferred despite the greater 
efficiencies of incorporation into albumin with the label led amino acid. The ad-
vantages displayed by 14co2 arise out of the fact that arginine production is al-
most if not entirely confined to the liver. (69, lOl) 
Af h d · · · f 14c ·d· · · d" ·b · d ter t ea mrn1strat1on o guan1 rne argrnrne, 1stn ut1on to, an 
labelling of many body tissue proteins occurs. The intracellular specific activity 
of the arginine used for the synthesis of these proteins will depend on the extent to 
which the incoming labelled amino acid is diluted with endogenously produced ar-
ginine. Since this dilution only occurs in the liver, precursor specific activities 
presented at the site of albumin synthesis will be lower than those at the extra-
hepatic sites of gamma globulin production. In the subsequent isolation of albumin 
from mixed plasma proteins, minimal degrees of contamination with gamma globulin 
f h. h "f" · · I · · (69) 0 h h h d h o 19 spec1 1c act1v1ty may resu t rn serious errors. n t e ot er an t e 
use of the 14c carbonate results in albumin of higher specific activity than that of 
gamma globulins, since the latter will become labelled only after 14c arginine pro-
duced in the liver has diffused to gamma globulin producing tissues and has become 
diluted with unlabelled arginine in the body water. (69) As a r~sult errors due to 
contamination with gamma globulins are reduced and rigorous protein purification 
methods become unnecessary. Furthermore, since body tissues are not significantly 
labelled after carbonate administration, recycling of the label is reduced to negli-
gible levels and in consequence the radiation exposure to which human subjects 
would be exposed is minimal. 
The fundamental / •......... 
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The fundamental assumption on which the 14c carbonate method is based, 
is that both urea and albumin are synthesised from the same pool of labelled arginine 
and the evidence upon which this assumption rests is indirect. Whilst there is 
I• I d b h h I ' · h I · f I b · od · (l l 2 - l l 4) h 1tt e ou t t at t e 1ver 1s t e on y site o a umm pr uct1on, t e 
f h . . . b . (115, 116) k' d k'd (11 7) d presence o extra epat1c argmase m ram, s m an I ney an 
plasma (l l S) raises the possibility of significant extrahepatic urea production. A 
serious objection to the validity of the method would be raised if this possibility was 
realised. Reeve (l07) has demonstrated the presence of 14c urea after adminis-
. 
14c · · h · d · I d K b (l l 9) . d th t termg arginine to epatectom1se an1ma s, an orn erg estimate a 
2% of 14c urea produced after bicarbonate administration in intact cats was of 
extrahepatic origin. From their studies in hepatectomised dogs Tavill et al (l 20) 
have confirmed the presence and activity of extrahepatic orginase. Quantitative 
estimation however revealed that in terms of the normal body urea pool, the amount 
synthesised was insignificant and amounted to less than 2% of the normal urea syn-
thesis rate, However when 14co2 was administered to hepatectomised dogs, no 14c d f' · h 14co · · ' h I urea was recovere , con 1rmmg t at 2 mcorporat1on into t e urea eye e 
does not occur to any measurable extent in extrahepatic sites. The carbonate label 
is therefore once again to be preferred, for its use will minimise any errors due to 
extrahepatic urea production. Though albumin and urea are exclusively synthesised 
in the liver the possibility exists that intracellular specific activities at the respec-
tive sites of albumin and urea synthesis ore different. Whether such differences 
exist or not is unknown, and as Tavill et al (l 20) have pointed out until subcellular 
fractionation is undertaken to determine if specific activity differences exist, the 
issue will remain purely speculative. 
It is also necessary to make the assumption that during the period of lobe II ing, 
the relative rates of urea and albumin synthesis remain constant. If these rates of 
synthesis were subject to variation, the situation might arise where albumin was syn-
thesised when precursor arginine specific activity was high, and urea might be syn-
thesised later when the precursor specific activity had fallen. Whilst there appears 
to be no reason to suspect rapid fluctuation in albumin synthesis (l 20) urea synthesis 
· 'd I f · · k (l 07' 136) F h • · h b may increase rap, ya ter protein into e. or t 1s reason 1t as een 
procedure to exclude protein from feeds for some hours prior to the start of the experi-
men t. / .................. . 
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ment. Though the period of labelling is short, the albumin synthesis rate calculation 
remains dependent upon the maintenance of a steady rate of urea synthesis throughout 
the synthesis interval. Possible fluctuations in the fractional synthesis rate of urea 
during this period in which it is being measured is prevented by similarly restricting 
protein intake. This principle was adopted in this thesis and full details are pro-
vided under Experimental Protocol. 
THE UREA SYSTEM 
The procedures used (l l l' 120) for calculating the FSR and the maximum specific 
activity of urea carbon are based on the assumption that there is flash label I ing of 
the precursor arginine pool, and that the 14c urea formed from this precursor arginine is 
distributed as a pulse throughout a single body urea pool. After distribution, the 
rate at which the labelled molecules disappear is taken as the FSR of urea since the 
fol I in radioactivities reflects the addition into the body pool of newly synthesised 
unlabelled urea molecules. The value obtained by extrapolation of the semi log 
plot of urea carbon specific activities back to zero time is taken as the theoretical 
maximum specific activity of urea (measured as the specific activity of the urea 
carbon atom). In the light of more recent work, it has become apparent that this 
simplified approach is in need of modification. 
(i) Measurement of urea fractional synthesis rate: 
(111 ) (121 - l 23) It has been noticed, and later confirmed, that the slope 
of endogenously produced 14c urea activities in the plasma are consistently less 
steep than those of pre label led urea administered intravenously. Jones et al (1 21 ) 
have explained this observation on the basis of continued incorporation of the 14c 
label into hepatic arginine when carbonate is used, and have concluded that the 
assumption that there is flash labelling of precursor arginine is invalid. Endo-
genously produced 14c urea would reflect the true fractional synthesis rate of urea 
only if it was rapidly freed from the liver as a single pulse. Since this condition is 
not fulfilled, the use of the endogenously produced 14c urea will result in values for 
the fractional synthesis rate and maximum specific activity, derived by back extra-
polation of the graph/ ••.••.• 
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polation of the graph to zero time, to be underestimated. In order to circumvent 
this difficulty, it has been proposed (l 2l, 123) that 13c urea should be administered 
intravenously simultaneously with the 14c sodium carbonate or, alternatively, pre-
label led 14c urea administered prior to the carbonate study, in order to obtain the 
true fractional synthesis rate of urea. 
(ii) Derivation of theoretical maximum specific activities of urea carbon 
The more recent procedure advocated by Koj and McFarlane O 23) takes 
cognisance of the fact that endogenously produced 
14c urea is delivered gradually 
into the body urea pool, maximum observed plasma specific activities being present 
f • I 30 • f h d · · • f 14c b (69 ' 1 o7) a ter approximate y minutes o t ea mm1strat1on o car onate. 
This procedure, the 11 area method 11 assumes instantaneous distribution of urea through-
out the body urea pool, and entai Is measuring the area under the 
14c urea specific 
activity curve (on linear paper) and multiplying this area by the plasma slope of 
simultaneously administered 13c urea. 
It is obviously desirable in the interests of greater accuracy to be able to 
implement these modifications. Unfortunately it has not been possible to do this in 
the experiments reported in this thesis. In the first instance facilities for the use of 
the stable isotope 13c were not available, whilst the use of small animals (which 
limited the amount of blood that could be sampled) and the particular experimental 
design chosen made it extremely difficult to derive the additional information re-
quired with exogenous 14c urea. In the light of these difficulties, the author has 
been obliged to derive the urea FSR and maximum specific activity from the plasma 
14 
curve of endogenously produced C urea. 
There is some difference of opinion as to the magnitude of the error that may 
be introduced into the final albumin synthesis rate value by omitting these modifi-
cations. Koj and McFarlane (l 23 ) have reported this error to be in the order of 
~ 10%. On the other hand Rothschild (l 24) has found no significant difference 
between the plasma slopes of exogenous 14c urea or endogenous 14c urea in either 
fasted or fed rabbits. Jones et al (l 2 l) believed that since the argument for continued 
incorporation / ••.••.•...•••• 
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incorporation of the precursor label almost certainly applies to albumin as well as 
urea, the inaccuracies inherent in adopting the flash labelling hypothesis ore to an 
extent mutually compensating and the final error is unlikely to be of serious propor-
tions. 
It remains to be pointed out that the methods employing exogenously labelled 
urea for measuring the FSR and maximum specific activity of urea both assume that 
the plasma urea specific activity is a single exponential, reflecting the synthesis and 
catabolism of urea within a single body pool. The recent studies of Jones et al (l 2l) 
have shown that the plasma curve in fact consists of two exponentials suggesting that 
labelled urea behaves in the body as if there were two comportments. At the time 
of writing this thesis no published reports have been received on the implications of 
these findings. 
Observed plasma urea specific activities may be altered in two additional 
ways. In the first instance alterations may occur due to extrahepatic urea synthesis. 
This question was discussed on Page 25 where it was concluded that when the carbonate 
label is used, extrohepatic urea synthesis is negligible and may be disregarded as a 
potential source of error. The last remaining possible source of error in respect of 
the plasma urea specific activity slope may be on outcome of endogenous catabol ism 
of urea in the gut by ureose containing bacteria. As a result, 14c urea after diffusing 
to the gut may be split into 14co2 and ammonia, the 
14c label recycled and used 
again for urea synthesis. This problem has been investigated by Regoeczi et al (l 09) 
and Mcfarlane et al (l l l) who have shown that whereas extensive recycling of the 
label occurs with 15N urea, recycling of the 14c label after 14c urea administration 
is negligible, the latter being eliminated via the lungs. Whilst treatment with Neo-
mycin reduced the amount of urea catabol ised in the gut, such treatment had no 
effect on the fractional rote of urea synthesis (l 09) when the 14c label was used. 
One may conclude again that endogenous catabol ism of urea does not introduce 
significant error into the method when a 14c label is used. 
THE ALBUMIN SYSTEM 
Losses of introvascular 14c albumin resulting from catabol ism and diffusion into the 
extrovascular / •.•......... 
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extravascular spaces have to be measured in order to obtain the theoretical maximum 
specific activity of albumin, (measured as the specific activity of the guanidine car~ 
bon atom). Whereas 14c urea may be detected in the plasma within a few minutes 
after 14c carbonate injection! the first appearance of 14c albumin occurs 30 - 60 
minutes later, (691 120, 123) the delay representing the time taken for newly syn-
thesised albumin molecules to be transported from the sites of synthesis on the endo-
plasmic reticulum to the blood stream. ( 125 , 126) 
Loss of 14c albumin may be measured by making reference to the disappearance 
of a pulse of 1
25 
or 
131 I labelled albumin injected simultaneously with the 14c 
carbonate 1 making due allowance for the gradual delivery of 
14c albumin into the 
plasma. The use of an intravenous dose of iodinated albumin rests on two assumi:r 
tions, firstly, that 
14c albumin is also delivered directly to the intravascular com-
partment and not via the lymph channels, and secondly that iodinated albumin may 
be regarded as representative of the behaviour of 
14c albumin. The first assumption 
has been validated by the studies of Smallwood et al (l 25) and the second assumption 
has been proven in a number of studies previously referred to in which the "in vivo" 
behaviour of 14c and iodine labelled albumin was compared. (651 85 - 87) The 
area method which has been suggested for measuring 
14c urea losses, is on theoretical 
grounds not suitable for correcting albumin 
14c losses because of the multi~exponen-
tial nature of the iodinated albumin plasma curve. (l 23 ) The strength of this ob-
jection has been assessed by Koj and McFarlane (l 23) with the use of digital and 
analogue computers, and on the basis of their findings it was concluded that for syn-
thesis intervals of the order of 200 - 300 minutes, satisfactory accuracy was still 
achieved when an area method was used. The method requires the time course of 
the appearance of 
14c albumin to be determined and the integrated gugnidine carbon 
radioactivities in the plasma to be multiplied by the fractional rates of loss from the 
plasma 0 the latter derived by graphic analysis of the iodinated albumin plasma curve. 
In this thesis practical considerations have governed the choice of a more ele-
mentary method of correcting for 
14c albumin losses. Whilst there was no reason to 
suspect that the time of arrival of 
14c albumin in the plasma would vary amongst the 
different groups of experimental animals, (this depending on transport factors alone) 
. . I 1t was qurte •..•..••.•••.•• 
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it was quite conceivable that the area of the 
14c albumin plasma curve might vary, 
not only between the different groups of animals, but also within each group at the 
beginning and end of the study period. The accurate definition of the time course 
of 14c albumin under these varying conditions would have been prohibitive in terms 
of both time and expense, particularly since a single rat would not have provided 
sufficient plasma for the description of the curve in its entirety, and the curve would 
have had to be derived from the plasmas of a number of rats. In addition the accurate 
definition of the iodinated albumin plasma curve throughout the six hour synthesis 
rate period would have greatly increased the volume of blood sampled, possibly re-
sulf'ing in altered glomerular filtration rates and upsetting the steady state conditions 
with respect to urea metabolism. 
125 131 . 
The procedure adopted therefore was to compare I or I albumin 
radioactivities in similar aliquots of plasma at zero time and again at the end of the 
h . .od h b h d I h (120, 124, 127, 137) syn t es 1s rate pen as as een t e proce ure e sew ere. 
The observed 14c albumin specific activity at the end of the synthesis rate interval 
was multiplied by the amount which the iodinated albumin had been observed to 
decrease. In using this approach the author is aware that allowance has not been 
made for the gradual arrival of 14c albumin in the plasma. 
A final point concerning the time courses of urea and albumin in the blood 
requires to be mentioned. Since albumin molecules only appear in the blood after 
30 minutes of injecting the carbonate, hypothetical albumin specific activity at t 
0 
should be compared in the synthesis rate formula with similar urea specific activities 
that would have existed at t - 30 minutes. The magnitude of the error associated 
0 
with omitting this additional refinement is smal I and the correction may be omitted 
. I (123) 
entire y. 
Because the validity of the carbonate method is not dependent on the exis-
tence of prolonged steady states, it is wel I adapted for use in metabolically unsteady 
conditions. It also offers the means whereby albumin synthesis may be measured in-
dependently of albumin catabolic rate, the former method studying the incorporation 
of 
14c into albumin, and the latter the elimination of iodine from albumin. This 
statement requires/ •••••••• , 
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statement requires a minor qualification since the synthesis rate method is connected 
with catabolism insofar as catabolism will account for some of the losses of 
14c al-
bumin molecules, which will require to be assessed and corrected for. 
Synthesis and catabolic rates as measured by these two methods have been 
compared under steady state conditions and satisfactory agreement has been achieved 
. b f d. (69, 106, 120, 127, 12a) s· h h . . d in a num er o stu 1es. ince t e synt es1s rate 1s measure 
over a short period of hours, and the catabol ic rate represents the average value ob-
tained over a number of days, it seems unlikely under these circumstances that better 
agreement could be expected. The newer techniques described (l 29) for the short 
term measurement of the catabolic rate seems to hold greater promise of effecting 
better agreement between synthesis and catabolic rates. 
Indirect Methods of Measuring Albumin Synthesis 
The experiments reported in this thesis represent the first direct measurement 
of albumin synthesis after hypophysectomy and growth hormone replacement therapy 
after hypophysectomy. Since it will be necessary to compare the present data with 
that obtained by previous workers, some of the indirect methods by means of which 
these investigators measured albumin synthesis require to be mentioned. 
By measuring the total amount of albumin catabolised over an experimental 
period and comparing this with the change in the total albumin pool in the body 
over the same period, an indication is obtained of the amount by which the synthesis 
rate differs from the catabolic rate, and this approach has been used by Rothschild (l 30) 
to determine the extent to which increased synthesis had offset the effects of experi-
. . (57 131 l 32) 
mental I y induced hypercatabol 1sm. Other workers ' ' have based syn-
thesis rate measurements on the plasma albumin specific activity curve, on the assump-
tion that the fol I ing specific activity reflects only the rate of addition of newly syn-
thesised unlabelled molecules to the plasma. This approach is of doubtful value since, 
as discussed previously, plasma specific activities are comp I icated by the additional 
contribution of albumin of higher specific activity returning from the extravascular 
compartments/ •..••••.•••••. 
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compartments, which in unsteady states may occur at varying rates. A more useful 
procedure was proposed by Matthews (l Ol) which gave a combined value for albumin 
synthesis and transfer of albumin molecules from the extravascular compartment. 
Whilst the individual contributions to the combined "synthesis plus transfer rate" 
could not be determined, approximate values could be obtained by means of an 
analogue computer. (l 33) 
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CHAPTER THREE 
PART l. MATERIALS AND METHODS 
ANIMALS 
Male albino rats of the Wister strain bred at this Medical School, and 
weighing between 230 g. and 260 g. were chosen for investigation. The rats 
were housed in single cages, and fed a standard rat cube diet (Vereen iging Con-
solidated Mills Limited, Cape Town) containing 20% mixed protein. 
SURGICAL PROCEDURES: 
(l) Hypophysectomy was performed under ether anaesthesia by the author via 
the parapharyngeal route. (60) The trachea was intubated with a fine polythene 
tube and the base of the skull drilled with an electric powered dental drill. The 
gland was aspirated into a finely drawn out glass pipette· and in al I cases the three 
pituitary lobes were identified in the glass pipette after aspiration. By this means 
a complete hypophysectomy was assured since experience had shown that the lobes 
themselves do not fragment. In addition the pituitary fossa was carefully checked 
at post mortem after the experiment for complete removal of the gland. Fulf detaifs of 
the operative technique are provided in the append ix. 
(2) Sham operation. The sham operation carried out was identical in all respects 
to the hypophysectomy, save that the pituitary gland was left intact after drilling 
the base of the skull. 
MATERIALS: 
(i) 131 Iodine and 125 iodine were obtained from the Radio-Chemical 
Centre, Amersham, (Bucks. U.K.), as carrier free preparations, free from reducing 
agent. 
(ii) 14c Sodium carbonate (S .A. 20 - 40 mC/m-mole) was obtained from 
Phi II ips-Duphar, Holland as an aqueous solution. This preparation was diluted with 
normal saline to provide a concentration of 0.5mC/ml, and stored in sealed sterile 
pyrex tubes unti I used. 
(iii) Bovine Growth/ .. , ..... . 
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(iii) Bovine Growth Hormone (NIH- GH- B14). The highly purified 
hormone was supplied by the Endocrinology Study Section of the National Insti-
tutes of Health and had a mean potency of 1.04 U.S.P. units per mg. Solution 
was achieved at pH 9 by the addition of 0.1 ml. of normal saline, and 0.05 ml. 
of 0.1 N NaOH per mg. of hormone. The volume was then adjusted with normal 
saline, so that the daily dose of 0.25 mg. could be delivered subcutaneously in 
0.5 ml. The characteristics of this hormone preparation as determined by the 
National Institutes of Heal th are presented in ful I in the appendix. 
PLASMA ALBUMIN CONCENTRATION: 
Plasma albumin concentration was determined by the method of Fernandez 
et al (67) in which after the preliminary removal of globulins with HCl-ethanol, 
albumin was precipitated with 0. 2M sodium acetate in absolute ethanol, and 
quantitated colorimetrically with Biuret reagent. Samples were read after thirty 
minutes against a known standard of bovine albumin on a Zeiss PM Ql l spectro-
photometer at 545 JJ. Since available samples of plasma were frequently small in 
volume, the method was scaled down for use on half volumes. 
ELECTROPHORESIS: 
Cellulose acetate electrophoresis was carried out in 0. 05M veronal 
buffer (pH 8.6). A current strength of 0.3mA per centimeter width of strip was 
applied for one and a half hours. Staining and clearing of the strips was achieved 
by immersion in 0.2% (w/v) Ponceau S stain and l 0% (v/v) acetic acid respectively. 
PLASMA UREA CONCENTRATION: 
Plasma urea concentration was determined on a Technicon autoanalyser as 
described by Marsh et al. 0 39) 
PREPARATION OF RAT ALBUMIN: 
Globulins were precipitated from plasma with 50% saturated ammonium 
sulphate at 37°. (64) Albumin was precipitated from the supernatant fluid by 
adjusting/ .............. . 
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adjusting the pH to 4.5 with l 0% (v/v) acetic acid. The supernatant fluid was dis-
carded and the albumin precipitate redissolved in distilled water. To remove any 
residual salt the sample was dialysed overnight at 4°C against distilled water. After 
dialysis the concentration was adrusted to 3 g% (w/v), and its homogenecity checked 
by cellulose acetate electrophoresis. Generally 5% of contaminating globulins were 
found to be present by this method of preparation. 
PREPARATION OF 1251 OR 131 1 LABELLED RAT ALBUMIN 
Iodination of rat albumin was performed by the iodine monochloride method, (76) 
and full details are provided in the appendix of methods. A mean level of substitution 
of less than one atom of radioiodine per albumin molecule was achieved. 
(i) For catabolic rate studies 131 1 was used. After iodination one ml. of 
fresh rat plasma was added to the iodinated albumin to prevent self irradiation damage. 
This was followed by ammonium sulphate precipitation and dialysis as described above. 
In this way free 131 iodide, residual salt, and any contaminating labelled globulins 
were effectively removed. Trichloroacetic acid precipitation on the final preparation 
showed that greater than 99% of the radioactivity was protein bound. The iodinated 
sample was subjected to eel lulose acetate electrophoresis and the radioactivity was 
shown to reside only in the albumin fraction. Normal saline was added so that 
approximately 20/Jc of 131 1 albumin was contained in l ml., after which sterilisation 
was achieved by "mil Ii pore" filtration. 
(ii) 
1251 1311 or • 
For synthesis rate measurements, albumin was label led with either 
Free radio iodide was removed by passing the sample through a column 
of Deacidite resin in the chloride form after which 99% of the radioactivity was shown 
to be precipitable with trichloracetic acid. The sample was diluted with normal 
saline and the 
14c sodium carbonate solution, to provide doses of iodinated albumin 
of approximately 4 ,µC/ml., and then steri I ised by "mil I ipore" filtration. 
PLASMA VOLUME: 
This was determined by isotope dilution using 131 1 or 1251 labelled rat albumin. 
RAT GROWTH/ ........... . 
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RAT GROWTH HORMONE: 
In order to determine the time taken for endogenous growth hormone to dis-
appear completely from the body, rat growth hormone (RGH) was measured by radio-
immunoassay in a randomly selected group of animals for nine days after hypophysectomy. 
Highly purified R. G. H. was iodinated by the method of Hunter and Greenwood (74) 
and in addition served as reference standard. Monkey anti R.G.H. antibody was 
used in the assoyu and separation of antibody-bound and free 
131 1 R.G.H. complexes 
h. d b h I h ' (l 40) was ac 1eve y c romato,oe ectrop ores1s. 
PLASMA CORTICOSTERONE: * 
Total 11 hydroxycorticoids in the plasma were measured by the method of 
Mattingly. (l 4l) Since in the rat the rat'io of corticosterone to cortisol is approxi-
mately 7: l 1 total 11 hydroxycorticoids are hereafter for convenience referred to as 
plasma corticosterone. 
MEASUREMENT OF ALBUMIN CATABOLIC RATE 
Thyroidal uptake of radio iodine released by catabolism was prevented by the 
provision of 0.005% (w/v) sodium iodide in the drinking water for 48 hours prior to, 
and for the duration of all catabolic rate studies. Urinary excretion of the label 
was measured indirectly by means of the daily fall in whole body gamma radiation. 
Approximately 20 JJC of 131 1 labelled rat albumin was administered intra-
venously into a tail vein under light ether anaesthesia. Total body activity was 
assayed immediately, and ten minutes after injection, the rats were bled from the 
tip of the tail for plasma volume, and 'Day O' plasma albumin specific activity 
determinations. Whole body activity and plasma albumin specific activity was 
determined daily at the same time for the duration of the experimental period. 
* 
Whole body activity was measured in a small whole body counter consisting 
Measured in the Department of Chemical Pathology with the assistance of 
Dr K. Arntsen. 
of a ring of six / ••.....••.. 
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of a ring of six matched G26 Pb Geiger-Muller tubes. Pulses were fed via a Probe 
Unit (Ekco type N558) and recorded on an Ekco scaler (type N530G). The probe 
unit served to impose a constant Dead Time of 200 JJ sec. on all pulses, thus facili-
tating accurate Dead Time correction over a wide range of observed counts. Ob-
served counts were corrected for Dead Time by the formula:-
N (corrected) = N (observed) l - N (observed) x X 
where ~ = Dead Time. 
Dead Time corrections were neglected once the whole body activity fell below 150 cps. 
Plasma activity was assayed on small aliquots (0.02 ml.) of plasma in a Packard 
Autogamma Spectrometer. Sampling errors were minimised by the use of sol id anti-
coagulant and constriction micropipettes. Plasma was also obtained daily for the 
determination of the albumin concentration. After correction for decay by means of 
appropriately made up standards, and after Dead Time corrections, the daily absolute 
and fractional catabol ic rates were calculated from the fol lowing formulae:-
(101) fol I in whole bod activit on Da n C/da ) Absolute CR (mg/day) = ----,.--...,..,.. ........ --.......... ----..__......_ ......... ___._.........,._..,.._.. 
mean p asma a bumin specific activity on Dayn YJC mg 
albumin) 
, . • fol I in whole body activity Fractional catabol rc rate(% rntravascular pool/day) = D 
on ay n x l 00 
mean plasma activity 
on Day n 
MEASUREMENT OF ALBUMIN SYNTHESIS RATE: 
Albumin synthesis was measured over a six hour period. In the normal control 
rats, and in those experimental rats eating ad I ibitum, albumin synthesis rate was 
measured after a l O - 12 hour fast. In the pair fed rats, the quantity of food provided 
on the preceding day was often rapidly consumed. In this instance the synthesis rate 
measurenientwasprecededbyafostof 12- 16 hours. In all cases food was withheld 
during the six hour period of measurement but free access to drinking water was per-
mitted at al I times. 
Under I ight ether/ •.......... 
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Under light ether anaesthesia approximately 200 pC of 14c sodium carbonate, 
and 2pC of 1251 or 131 1 labelled rat albumin was administered simultaneously by 
intravenous injection at the base of the tail. Ten minutes later the rats were bled 
from the tip of the tail for determination of the plasma volume. Half hourly, from 
hours three to six, smal I (O. l ml.) samples of blood were obtained from the tip of 
the tail for the determination of urea carbon specific activities. At six hours the 
rats were lightly anaesthetised with ether and exsanguinated by cannulating the 
aorta. Albumin guanidine carbon specific activity, and albumin and urea concen-
trations were determined on this final sample of plasma. Aliquots of plasma from 
the ten minute and final bleedings were counted in order to provide the correction 
factor for the albumin guanidine carbon specific activity, as explained in Chapter 2. 
Once post mortem examination revealed the absence of pituitary gland tissue 
the appropriate blood and plasma samples from four rats were pooled prior to pro-
cessing. Full details of the laboratory methods and the calculations required for 
the determination of the albumin synthesis rate are provided in the Appendix of 
Methods. 
In broad outline, the laboratory procedure of measuring albumin synthesis 
depends on the enzymatic conversion of urea carbon to CO2 with urease. The 
volume of CO 2 I iberated is measured in a calibrated manometer and then trapped 
in a phenylethylamine-methanol mixture which in turn is transferred to a liquid 
scintillation mixture and assayed for radioactivity. Calibration of the manometer 
with known standard urea solutions makes it possible to convert volumes of CO2 to 
mg. C, and, after radioactive assay, to express urea carbon specific activities as 
C.P.M./mg. C. Since the volumes of enzymatically produced CO2 are small it 
is necessary to undertake their measurement on a high vacuum gas-train. Working 
pressures of l to 3 x l 0-3 mm. Hg. were achieved by a two stage high vacuum 
pump. By differential freezing with liquid nitrogen and solid CO2-ethanol, the 
CO2 sample may be further freed from any contaminating gasses remaining in the 
system. The high vacuum gas-train used was designed and constructed locally by 
Hoffenberg (l 42) and is depicted in the appendix. 
For urea carbon / ........ . 
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For urea carbon specific activity measurement, samples of whole blood were 
first deproteinised and then incubated with urease. The volume of liberated 
14co2 
was measured manometrically on the high vacuum gas-train as outlined above, and 
then condensed into phenylethylamine-methanol f 4J) at the temperature of I iquid 
nitrogen. After thawing, the phenylethylamine was transferred quantitatively to 
a scintillation mixture and counted in a Beckman Liquid Scintillation Counter. 
Albumin guanidine carbon specific activity was measured on albumin extracted 
from plasma by the method of Korner and Debro. (66) Cellulose acetate electro-
phoresis consistently demonstrated the absence of contaminating globulins after the 
extraction processes. The protein was subjected to acid hydrolysis and the resultant 
amino acid residue incubated with arginase thus splitting off the guan idine group to 
yield urea. This urea was processed for specific activity measurement in identical 
fashion to that described above. 
The slope of the semi log plot of the fol I ing urea carbon specific activities 
from blood sampled over the three hours provided the fractional synthesis rate of urea, 
and back extrapolation of the graph to zero time (t ) gave the theoretical maximum 
0 
specific activity of urea carbon. In order to obtain the maximum (t0 ) specific activity 
of albumin guan idine carbon, the specific activity observed at six hours was increased 
by a variable factor derived from the disappearance (from the intravascular compart-
ment) of the iodinated albumin administered simultaneously with the 14c sodium car-
bonate at the beginning of the experiment. Fractional and absolute synthesis rates 
were then calculated as follows:-
Fractional synthesis rate albumin (% IVP/hour) = 
fractional S. R. urea (%/hour) x S.A. Albumin to 
S.A. urea t0 
Absolute S. R. (mg/hr.)= fractional S. R. x I. V. P. 
where I. V. P. = albumin concentration x plasma volume. 
These hourly values were multiplied by twenty-four to provide an average daily value. 
Part2 / •...............•.... 
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PART 2. EXPERIMENTAL PROTOCOL 
The object of this thesis was to ascertain what role, if any, growth hormone 
has in regulating albumin metabolism. Albumin synthesis and catabolic rates have 
therefore been measured under conditions of growth hormone deficiency, and after 
growth hormone replacement therapy. It was decided to conduct the investigation 
in rats firstly because it was anticipated that large numbers of animals would be re-
quired, and secondly because hypophysectomy is most easily performed and carries 
the best chance of success in this animal. Since growth hormone is not a trophic 
hormone i.e. it does not act via a target endocrine organ, growth hormone de-
ficiency can only be produced by anterior hypophysectomy. However, in order to 
avoid confusion when the pituitary fossae were examined at post mortem for gland 
remnants, it was decided to perform a total (anterior and posterior) hypophysectomy. 
Since rat growth hormone is not commercially available, replacement therapy 
was achieved by using bovine growth hormone supplied in pure form by the National 
Institute of Health. Since the hormone derives from a higher species it is biologi-
cally active in the rat. (l 44) The dose of 0.25 mg/day was chosen empirically to 
correspond roughly with that used by other workers. Ideally the replacement dose 
chosen should be aimed at providing physiological replacement, but in the absence 
of any data to suggest a comparable amount of bovine growth hormone to replace rat 
growth hormone, the dose of 0.25 mg/day was selected and would appear to be suit-
able since clearcut effects on many aspects of intermediary metabolism are achieved 
at this dosage level. (32 ) Growth hormone injections were commenced twenty four 
hours before hypophysectomy and given daily until twenty four hours before the syn-
thesis rate experiments. Given in this way growth hormone effects would cover the 
t . • d (l 74) d d d" . . h d . opera 1ve perio an stea y state con 1t1ons wit respect to urea pro uct1on 
would not be jeopardized by growth hormone administered shortly before the synthesis 
rate measurement. (l 74) 
In view of the short half life of growth hormone, (l 45 , 146) it was antici-
pated that the effects of growth hormone deficiency would manifiest rapidly after 
hypophysec tomy and for th is reason the study was confined to the first nine days after 
hypophysectomy. 
The presence / ............. . 
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The presence of anorexia in the hypophysectomised rot necessitated the in-
clusion of an additional group of control rats in which this factor was assessed. 
This problem could be tackled either by force feeding hypophysectomised rats, 
or, by restricting the food intake of intact rots. On theoretica I grounds force 
feeding hypophysectomised rots is to be preferred but this technique (requiring 
the passage of a stomach tube) is at the best of times a traumatic procedure, and 
it was felt that in rats just recovering from the effects of surgery the additional 
manipulations involved would not only prevent wound healing, but severely pre-
judice their chances of survival. In the I ight of these difficulties it was decided 
to pair feed intact rats with hypophysectomised rots eating ad I ibitum. The effect 
of surgical intervention per se, was assessed by subjecting these rats to a sham 
operation. 
The experiments were designed as fol lows:-
Albumin Catabolic Rate Studies 
Albumin catabolic rate was measured in four groups of rots 
Control group (16 rats) 
11 Experimental groups 
(a) Hypophysectomised group (9 rats) 
(b) Pair fed sham operated group (5 rots) 
(c) Hypophysectomised group receiving growth hormone 
replacement therapy (9 rats) 
The sixteen normal control rats were studied over a period of eight to ten 
days. The catabolic rate of each individual rat was determined on a daily basis, 
the daily values then being meaned to provide an average value for the ten day 
period. The average values for each of the sixteen rats were then meaned to give 
an overall normal value for albumin catabolism. 
In the three experimental groups of rats, the tracer dose of albumin was 
injected and the pre-operative catabolic rate first established on a daily basis 
over a period of/ ..........•• 
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over a period of three or four days. These daily values were meaned to obtain a 
single average preoperative value. Hypophysectomy or sham operation was then 
carried out and the fractional and absolute catabolic rates determined daily for 
nine days thereafter. This approach not only made it possible for the rats to act 
as their own controls both before the operation and throughout the nine day study 
period, but also made it possible to check on the quality of the tracer dose by in-
specting the pre-operative catabol ic rate as explained in chapter 2. 
Albumin Synthesis Rate Studies 
The large amounts of plasma or blood required, and the need for complete 
elimination of circulating isotopes precluded serial synthesis rate determinations in 
the same rats as was possible when the catabolic rate was measured. Equal aliquots 
of blood or plosma from four rats was therefore pooled to provide each separate syn-
thesis rate value. 
Normal control values were obtained on nine such batches of rats (36 indi-
vidual rats). In the three experimental groups (as above) the synthesis rate was 
determined on Days 2, 4, 6 and 9 post-operatively. On Days 4 and 6 the synthesis 
rate was measured in two batches of rats, but in order to permit statistical compari-
sons between observations made at the beginning and end of the study period, a total 
of six batches were studied on Days 2 and 9. 
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CHAPTER FOUR 
RESULTS 
l. FOOD CONSUMPTION 
The average quantities of food consumed daily by the normal control rats, 
and by the three experimental groups of rats, are presented below in figure 4: l . 
Normal values were derived from forty rats observed for a period of not less than 
two weeks. In respect of the quantities of food eaten by the three experimental 
groups of rats, the following features require to be noted. 
(i) At all times the daily intake of these groups is well below the 
average normal intake. 
(ii) As the hypophysectomised rats (eating ad I ibitum) recovered from 
the effects of the operation, larger quantities of food were consumed. The values 
depicted in figure 4:1 were derived from twenty-one rats observed daily for the nine 
day study period. 
(iii) The sham-operated group of rats, which were pair fed to the hypo-
physectomised rats, made a swift recovery from the effects of the operation and it 
was clear from the eagerness with which the daily rations of food were consumed 
that their normal appetite was retained. The daily food ration was always com-
pletely consumed so that the graphs for this group of rats and the hypophysectomised 
rats coincide exactly. 
(iv) Bovine growth hormone appears to have no significant effect on the 
anorexia present after hypophysectomy since quantities of food eaten by the growth 
hormone treated rats eating ad libitum were of the same order as the untreated hypo-
physectomised rats. Here again this conclusion is based on observations made on 
twenty-one rats treated with growth hormone for nine successive days post-operatively. 
2. DISAPPEARANCE OF PITUITARY HORMONES AFTER HYPOPHYSECTOMY 
A successful hypophysectomy was readily evident from the precipitous and 
persistent weight loss, anorexia and lethargy displayed by the rats after the operation. 
Biochemical/ •.............. 
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Biochemical confirmation of hypophysectomy was obtained in a smal I series of 
rats displaying the clinical features of hypophysectomy by measuring plasma growth 
hormone and corticosterone levels on days 2, 4, 6 and 9 postoperatively. Both 
these hormones disappeared rapidly from the plasma, and in eight rats shown at 
post-mortem to be successfully hypophysectomised, neither hormone was detectable 
in the plasma forty-eight hours after the operation. The possible implications of 
these findings will be discussed in chapter five. 
3. ALBUMIN METABOLISM 
(a) Control group 
The plasma albumin half-I ives and rates of synthesis and catabol ism obtained 
in the normal control rats are presented in Table A and are compared with those values 
obtained by other workers. In general there is satisfactory agreement suggesting that 
the albumin tracer used in the present study was biologically acceptable and that the 
values obtained represent the normal range in the rat, 
Table A/ •................... 
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TABLE A 
NORMAL RAT VALUES 
AUTHOR METHOD 
l . Fleck and Munro H. N. (l 39 ) 11 = 2 .8 days 
2 
1311 lb. a umm 
2. Cohen S. (216 ) T .1 = 2 • 8 days 
2 
F.C.R. = 73% 1.V.P./day 
1311 lb . a umm 
(166) 3. Freeman T. and Gordon A.H. 
1311 lb . 
4. Kirsch et al (l 27) 
5. Present study 
I. V. p. = 
A.C.R. = 
F .C.R. = 
A.S.R. = 
F.S.R. = 
T .1 = 2 .7 days 
2 
a umm 
F. C. R. = 76% I. V. P ./ day 
A.C.R. = 268mg/day/300g. rat ;~1 lalbumin 
A. S. R. = 280 mg/day/300 g. rat C carbonate 
T 1 = 2. 7 days 
2 
F.C.R. = 77.6% 1.V.P./day 
* 
1311 lb . a umm 
A.C. R. = 207 mg/day/240 g. rat 
F.S.R. = 73.5%1.V.P./day 14 C carbonate 
* A.S. R. = 200 mg/day/240 g. rat 
*range= 
230 g - 250 g 
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fractional catabolic rate 
absolute synthesis rate 
fractional synthesis rate 
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Figure 4:2 displays the normal values for plasma albumin half-life. The 
daily plasma activities of the sixteen rats (expressed as a percent of initial plasma 
activity) were meaned and plotted on log I in ear paper, and the best fitting I ine for 
those points after forty-eight hours plotted by the method of least mean squares. 
The mean plasma albumin half-life was 2.7 days with a standard deviation of 0.2 
days. The range of 2.4 to 3.1 days is also depicted in the diagram. 
It has not been the express intention of this thesis to evaluate the agreement 
between steady state measurements of albumin synthesis and catabolism by the two 
independent methods used. Since in most instances synthesis and catabol ic rates 
were not measured in the same rat, there is insufficient data to provide a measure 
of correlation between the rates of these two processes as measured by the two 
different techniques. The normal values obtained for synthesis and catabolism are 
displayed in table A. 
(b) Experimental groups 
The effects of hypophysectomy, sham operation and pair feeding, and hypo-
physectomy plus growth hormone treatment on albumin metabolism are presented in 
both diagramatic and tabular form, (Figures 4:3 and 4:4, and Tables B to E). 
Since values for absolute synthesis and catabolic rates will partly depend on 
the size of the intravascular pool, comparisons between various absolute values could 
be misleading if the animals were of different sizes. 
Despite the greatest care in group.ing rats of comparable body weight, plasma 
volumes varied as a result of the surgical and dietary manipulations. Absolute rates 
were not expressed in terms of body weight, since correction for change in body weight 
alone does not take into account the marked differences between the body composition 
of starved, hypophysectomised, and growth hormone treated animals (30, 361 37) upon 
which the plasma volume is to a large extent dependent. Animals of the same weight 
may therefore have plasma volumes that differ considerably. Fractional rates of syn-
thesis and catabolism not being affected by such changes have therefore also been pre-
sented. 
In figures 4:3 and 4:4 the hatched areas represent the mean ~ 2 standard 
deviations of the/ •......•.•.. 
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deviations of the values obtained from the normal control rats. Each synthesis rate 
value is derived from the pooled plasmas of four rats. The daily catabolic rate 
+ 
values for the three experimental groups of rats have been charted as the mean - l 
standard deviation. The values presented in figures 4:3 and 4:4 for the albumin 
concentration were those obtained in the catabolic rate studies, and these are also 
charted as the mean ~ l standard deviation. For the sake of clarity the albumin con-
centrations of the rats in which the synthesis rate was measured have been omitted from 
these diagrams, and are presented together with the synthesis rate data in Table B. 
The catabol ic rate data is presented in Tables C, D and E. 
Note: Values for the absolute catabolic rate and albumin concentration on 
days 4, 6 and 8 in the untreated hypophysectomised rats are not available. Early in 
this study it was felt that daily sampling might increase the post hypophysectomy mor-
tality rate. In an attempt to reduce the amount of blood sampled, on these days 
sufficient blood was obtained for the calculation of the fractional catabolic rate alone, 
but not the absolute catabolic rate nor albumin concentration. As experience was 
gained this precaution was found to be unnecessary and was dispensed with, so that 
complete data is available for the growth hormone treated hypophysectomised rats. 
For the interpretation of the data a number of comparisons both within and 
between the various groups were undertaken and evaluated statistically, The 
following comparisons were made:-
(l) Fractional and absolute synthesis rates on days 2 and 9 in the 
three experimental groups were compared with normal values (Table V). 
(2) Fractional and absolute catabol ic rates in the three experimental 
groups were compared with normal values. No table is presented but the relevant 
statistical data is included in the text. 
(3) In Table VI the synthesis rates on Days 2 and 9 post-operatively 
were compared with the catabol ic rates on the same days. Comparison is made 
within each experimental group only. 
(4) The absolute and fractional synthesis rates of each experimental 
group on Days 2 and 9 post-operatively were compared with those of the remaining 
two experimental / , ........ . 
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two experimental groups on the same days. The data is presented in Tables I and II 
respectively. 
(5) The absolute and fractional catabolic rates of each experimental 
group on days 2 and 9 post-operatively were compared with those of the remaining 
two experimental groups on the same days. The data is presented in Tables Ill and 
IV, respectively. 
The significance of differences between observed values was tested by the 
Mann- Whitney 'U' test. Wherever possible, exact values of Pare provided. Where 
sample sizes precluded this, critical values of 1U 1 are provided at the .001 and .01 
significance levels. Where the observed value of 1U 1 is less than or equal to the 
critical value of 1U1 then the difference between the two populations is significant 
at that significance level. The fol lowing convention was adopted in expressing values 
of 1 U1 : 
'U' b d Critical 1 U1 at .001 level 
0 serve · C ·t· I 1 U1 t 01 I I rr rca a . eve 
3 
e.g. 4 9 
The two populations that were compared are significantly different at the .01 level 
only, since 4 is less than 9 but greater than 3. 
p f .05 probably significant; p ~ .01 significant; 
p $ .001 highly significant. 
Full details of the statistical methods is provided in the appendix. 
Table B / ................ . 
Alb. cone. P.V. I. V. P. F.S.R. A.S. R. Alb. cone. P. V. I. V. P. F.S.R. A.S.R. 
g% ml. mg. % 1.V.P./day mg/do g% ml. mg. % I. V.P./da mg/do 
lormal 2.47 11 .43 282.3 74.4 210.0 Day 2 2.42 11. 92 290.8 54.9 159,6 
'alues 2.63 9.95 240.6 67.4 162.2 2.58 l 0.30 268.2 58.5 156. 9 
2.24 11 . 01 246.6 82.3 202,8 2. 17 8.43 183 .3 64.5 118 .3 
2,54 11 .80 299,7 76.5 229.4 2. 14 9.07 195.2 82.3 160.5 
2,43 11 .35 275.5 75.3 207.6 C: 2.32 9.11 212.3 47.7 l 01 .2 
2,88 9.97 287. l 72.4 208.0 0 0) 2.69 8 .51 229.5 49.6 114. 0 
·-
2.80 l 0.38 290.5 69.8 202.8 .... C: 4 2.21 11 . 21 247.7 46.8 115. 9 C ·-
2.57 l 0.28 264. l 70.3 185.7 .... ""O 2.53 l 0.07 254.7 48.0 122. l Cl) ""O Cl) 
2.54 l 0,05 255.5 73,6 188. l a. C: Cl) 6 l.65 9.56 158.0 66.7 l 05.3 Q Cu... 
2.21 11 .22 246.4 40.8 l 00.3 
Mean 73.5 199,6 I ~ .... ·- 9 2.42 9.84 240.0 51. l 122.6 2 S. D. 8.7 37.9 C a.. 2. 11 11 .68 246.4 60.4 149.0 ..c 
V) 2.21 8.38 185.2 66.0 114.0 
2.32 9. l 0 211 • l 62.6 132,0 
2. 11 8.94 187.8 81.8 153. l 
2.33 9.05 209. l 77.2 161 .5 
ay 2 1.75 9,25 161 .8 51.6 83.5 Day 2 1.56 9.73 152,4 57.3 87.3 
l.61 l 0.34 166.4 33.6 55.9 2. 14 l 0.35 222.2 66.9 148.5 
1.96 8.03 157.3 59,5 93.6 l. 91 9.05 172 .6 71.2 122.8 
2. 01 9.06 182. l 47.5 86.4 1.98 9.36 184.4 53.7 99. l 
>- 2. l 0 8.77 185,4 44.4 82.0 >- Cl) 2.06 8.72 179 ,3 64.0 114.7 
E 2.07 8.35 173 .2 40,3 69.6 E C: 1.89 l 0.05 191 .2 54.2 l 03.6 0 0 0 
.... 4 1.58 9.54 150.7 49.4 74.4 .... E 4 1.85 l 0.28 190. l 71.5 135.8 
u u .... 
Cl) 1.94 8.57 166.2 41.0 68. l Cl) "' 0 l.69 l 0.32 173.4 60.7 l 05. l 
"' 
"' :, J: 
>- 6 1.75 9.65 168.8 55.9 94.3 >-- 6 1.60 9.67 154.7 57. l 88.3 
..c: 1.78 8.94 159. l 30.2 48.0 ..c O...
c 1.56 10. 94 l 71 . l 66.7 114.0 a. a. .... 
0 9 1.50 6.84 l 02 .6 28.5 29.2 0 ~ 9 l.64 l 0.66 175.2 45.8 80. l a. a. 0 
>- 1.57 l 0.56* 165.7 21.8 36.2 >- .... 1.59 11 . 04 172. 9 54.9 94.8 
J: 2. 12 9,87* 209.3 31.6 66.2 J: 0 1.99 l 0.78 213.8 44.4 94.8 
l.73 6.65 116 .6 37.9 44. l 1.81 9.80 150,4 40.8 73.4 
1.57 6.29 99.5 25.4 25,2 1.77 9.15 163.8 36,0 58.8 
1.98 6. 12 121 .8 39. l 47.5 1.89 8.77 165.8 48.8 80. l 
Table B. The effect of hypophysectomy, sham operation and pair feeding, and hypophysectomy plus growth hormone treatment on albumin synthesis. 
Alb. cone. = albumin concentration; P. V. = Plasma volume; I. V. P. = intravascular albumin pool; F. S. R. = Fractional synthesis rate; 
A.S. R. = Absolute synthesis rate. 
* Unusually large plasma volumes resulted from prior sampling for catabolic rate measurements. 
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TABLE C PLASMA ALBUMIN CONCENTRATION (g%) 
MEAN 2 S.D. 
Normal Values 2.42 0.49 
Hypophysec tomy Sham 
operation and pair Hypophysectomy and 
feeding growth hormone 
Day Mean l S. D. Mean l S. D. Mean l S. D. 
0 2.60 0.27 2.49 0.30 2.38 0.30 
l 2.29 0.39 2.57 o. l 0 2. 11 0.33 
2 2.08 0.38 2.54 0. 17 1. 91 0.28 
3 1.98 0.46 2.60 0.23 1.78 0.35 
4 * * 2.54 0.16 1. 71 0.27 
5 1. 91 0.29 2.50 0.37 1.86 0.28 
6 * * 2.49 0.27 2,05 0.28 
7 1.82 0.32 2.45 0. 19 2.08 0.31 
8 * * 2.34 0.41 1. 95 0.39 
9 1.74 0.35 2.34 0.37 2.00 0.35 
TABLE D FRACTIONAL CATABOLIC RATE OF ALBUMIN (%1.V.P./Day) 
--
MEAN 2 S.D. 
Normal Values 77.6 15.3 
Hypophysectomy Sham opera
tion and pair Hypophysectomy and 
feeding growth hormone 
Day Mean l S. D. Mean l S. D. Mean l S, D. 
0 82 .1 7.6 81.2 7.7 82.7 5.7 
l 87.9 11.5 77.9 16.5 86.3 15.0 
2 l 03. 0 13.7 129.7 12.6 94.6 12. 1 
3 90.8 17 .4 79.9 22.8 92.4 17 .2 
4 78.4 17. 9 84. l 14. l 93.3 12.9 
5 76.5 11. 9 78.7 7.4 74.5 lo. 0 
6 53.5 11. 7 72.8 10.0 73.6 7.7 
7 51.2 16.0 75.2 12.4 66.4 12.5 
8 57.0 9.5 75.0 l 0. 0 66.6 12. l 
9 52.0 15.3 79.0 5.3 66.8 14.4 
TABLE E ABSOLUTE CATABOLIC RATE OF ALBUMIN (mg./day) 
MEAN 2 S. D. 
Normal Values 207.3 66.6 
Hypophysectomy Sham 
operation and pair Hypophysectomy and 
feeding growth hormone 
Day Mean l S. D. Mean l S. D. Mean l S. D. 
0 200.8 34.5 235.6 39. l 216,2 30.9 
l 186.2 48.2 218.6 34.5 194.4 34.3 
2 204.9 55.6 365.2 18.2 194.8 39.6 
3 177 .3 52.3 232.0 54.2 172 .3 37.6 
4 * * 214.0 45. l 171 . 8 34.5 
5 129.8 26.4 207.3 32.8 149.7 32.8 
6 * * 195. 8 26.8 163.6 38.6 
7 91.4 28.3 203.2 36.9 146.6 27.3 
8 * * 180.0 34.0 133. 9 21.8 
9 80. l 25.2 194.4 22.8 137.7 24.9 
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Figure 4:3 The effect of hypophysectomy, sham operation and pair 
feeding, and hypophysectomy plus growth hormone treat-
ment on plasma albumin concentration and absolute syn-
thesis and catabol ic rates. 
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Table 1. ABSOLUTE SYNTHESIS RATE COMPARISONS 
HX9 
PF 2 
PF 9 
GH2 
GH 9 
HX2 
.002 
• 001 
-
.002 
= 
HX9 
-
.001 
-
.002 
. 
PF2 
).409 
< .469 PF9 
.090 
- GH2 
- .001 .0041 
Table II. FRACTIONAL SYNTHES IS RA TE COMPARISONS 
HX2 
HX9 
PF 2 
PF 9 
GH 2 
GH 9 
.004 
.032 
-
.008 
-
HX9 
-
• 001 
-
.004 
PF2 
• 155 PF9 
.350 
- GH2 
- .002 .0041 
Table Ill. ABSOLUTE CATABOLIC RATE COMPARISONS 
HX2 
HX9 0 7 HX9 14 
PF 2 0 1 PF2 5 -
PF 9 0 1 P= .004 PF9 - 5 
GH 2 43 7 0 1 GH2 14 - 5 -
GH 9 3 7 1 1 8 7 GH 9 - 14 - 14 5 
Table IV. FRACTIONAL CATABOLIC RATE COMPARISONS 
HX2 
HX9 0 7 HX9 14 
PF 2 3 1 PF2 5 -
PF 9 2 1 P= .004 PF9 - 5 
GH 2 29 7 0 1 GH2 14 - -5 
GH 9 7 12 1 4 7 - 17 14 - GH 9 5 14 
. 
VI 
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Table V. COMPARISON BETWEEN EXPERIMENTAL SYNTHESIS RATE VALUES 
Absolute SR 
Fractional SR 
AND NORMAL VALUES ON DAY 2 AND 9 
HX2 HX9 PF2 PF 9 GH 2 GH 9 
0 2 0 2 0 2 0 2 0 2 0 7 7 7 7 7 
0 2 0 2 8.5 2 16 2 3 2 0 7 7 7 7 7 
The significance of the difference between the experimental 
absolute or fractional synthesis rates and normal rates is ob-
tained by choosing the appropriate horizontal and vertical 
column; e.g. the pair fed fractional synthesis rate on day 2 
is not significantly different from normal at either the . 001 
or .01 levels ( 8 . 5 ~ )'" Critical values of 
1 U1 are provided. 
2 
7 
2 
7 
Table VI. COMPARISON BETWEEN SYNTHESIS AND CATABOLIC RATES ON 
Absolute 
Fractional 
DAYS 2 AND 9. 
HX2 HX9 PF 2 PF 9 GH 2 GH 9 
0 2 4 2 p = .002 P = .002 0 2 2 7 7 7 
0 2 3 2 p = .002 P = .089 0 2 2 7 7 7 
The significance of the difference between the synthesis and 
catabolic rates in any one group of experimental rats on day 
2 or 9 may be determined by choosing the appropriate hori-
zontal and vertical columns; e.g. in the pair fed rats on 
2 
7 
2 
7 
day 9 the fractional synthesis rate is not significantly different 
from the fractional catabol ic rate since P = . 089. Where 
possible exact values of Pare provided, otherwise critical 
values of ·u· are presented. 
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EFFECT OF HYPOPHYSECTOMY 
A. Synthesis rate 
(i) Compared with normal values. 
After Hypophysectomy both absolute and fractional synthesis rates 
fell sharply and forty eight hours post-operatively were highly significantly less 
than normal (Table V). The values on days 4 and 6 were of the same magnitude 
but the day 9 values displayed a further slight fol I with the result that not only 
were they highly significantly less than normal, but also significantly less than 
the day 2 values. (Tables I and II). 
B. Catabolic rates 
(i) Compared with normal values. 
The absolute catabolic rate remained within normal limits for 
approximately four days but then fell and was highly significantly less than normal 
on the fifth day post-operatively (51j) The fall was initially rapid, but became less 
pronounced in the latter part of the study period. 
The fractional catabolic rate displayed a highly significant post-operative 
rise above normal values on day 2 (41j ). Thereafter the catabolic returned to 
normal levels but continued to fall and from day 6 onwards was highly significantly 
19 less than normal. (l 0.5 31 ) 
(ii) Synthesis and catabol ic rates compared. 
Absolute and fractional rates of catabolism were at all times higher 
than the corresponding synthesis rates. On day 2 catabolic rates were highly sig-
nificantly greater, but because of the reduction in catabolism, differences on day 9 
were less marked although still significant (Table VI). 
C. Albumin Concentration 
The plasma albumin concentration displayed a rapid fall during the first 
three days of the study period. Thereafter the fol I was less steep, the mean 
concentration/ .......... . 
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concentration falling below the second standard deviation of the normal values on 
day 7. 
EFFECT OF SHAM OPERATION AND PAIR FEEDING 
A. Synthesis Rates 
(i) Compared with normal values. 
Sham operation and two days of pair feeding resulted in a fol I in 
the absolute synthesis rate to values that were highly significantly less than normal, 
(Table V). The absolute synthesis rate continued to fall on days 4 and 6 but although 
the values rose on day 9, they were still highly significantly less than the normal 
(Table V). The values on day 2 and 9 were not significantly different from each 
other (Table I). 
The fractional synthesis rate though falling, was only probably 
significantly less than normal on day 2 (U (obs) = 8.5, U at 0.5 level = 12). 
The va I ues on day 4 were of the same order, but the two va I ues on day 6 were 
widely separated. The fractional rates on day 9 showed a continuing rise and were 
not significantly less than normal values (Table V) nor significatnly different from 
the day 2 values (Table 11). 
(ii) Compared with the synthesis rate in hypophysectomised rats. 
The absolute synthesis rate in the pair fed groups on days 2 and 9 
was highly significantly greater than that of the hypophysectomised group (Table I). 
The fractional synthesis rates of the pair fed group on day 2 was only probably sig-
nificantly greater than the hypophysectomised group but on day 9 was highly signifi-
cantly greater (Table II). 
B. Catabolic Rate 
(i) Compared with normal values. 
The response of both the absolute and fractional catabolic rates to 
sham operation / ••........... 
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sham operation and pair feeding was similar. The post-operative rise became 
highly significantly greater than normal on day 2 (0-?2), after which there was 
a return to the normal range, within which the values remained for the duration 
of the study period. 
(ii) Synthesis and catabolic rates compared. 
The absolute and fractional catabol ic rates were at all times greater than 
the corresponding synthesis rates. Absolute rates were significantly different on 
days 2 and 9 (Table VI). Fractional rates differed significantly on day 2, but 
there was no significant difference on day 9 (Table VI). 
(iii) Compared with the catabolic rate in hypophysectomised rats. 
The absolute catabolic rate in the pair fed group was highly significantly 
greater than that of the hypophysectomised group (Table Ill). Differences in the 
fractional catabolic rate were less marked but still significant (Table IV). 
C. Albumin concentration 
The plasma albumin concentration remained within normal limits through-
out the nine day study period. 
EFFECT OF HYPOPHYSECTOMY PLUS GROWTH HORMONE TREATMENT 
A. Synthesis Rate 
(i) Compared with normal values. 
The absolute synthesis rate after hypophysectomy and two days of 
growth hormone treatment was highly significantly less than normal (Table V) and 
furthermore fel I progressively during the remainder of the study period. 
The fractional synthesis rate behaved in an essentially similar fashion. On 
day 2 this was significantly less than normal and because there was a continued fall, 
the difference on day 9 became highly significant (Table V). 
Absolute and/ •.........•..• 
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Absolute and fractional synthesis rates on day 9 were significantly less 
than those on day 2 (Tables I and 11). 
(ii) Compared with the synthesis rate in the untreated hypophysectomised 
rats. 
On days 2 and 9 the absolute and fractional synthesis rates of the growth 
hormone treated rats were sign ificant!y greater than those of the untreated hypophy-
sectomised rats (Table I and II). 
(iii) Compared with the sham operated pair fed rats. 
On day 2 the absolute and fractional synthesis rates in these two groups were 
not significantly different (Tables I and II). However, on day 9 the absolute rates 
in the treated rats were highly significantly less than those of the pair fed rats. 
Differences in fractional rates were less marked but still significant (Tables I and II). 
B. Catabolic Rate 
(i) Compared with normal values. 
The absolute catabolic rate fel I slowly throughout the study period, becoming 
19 
significantly less than normal from day 7 onwards, (8 - 31 ). There was no early post-
operative rise. 
The fractional catabolic rate showed a post-operative rise to a value that was 
highly significantly greater than normal on day 2, (17 - ~r ). The catabolic rate then 
fell, and from day 8 was significantly less than normal, (29- ~r). 
(ii) Synthes is and catabo I ic rates compared. 
At all times the absolute and fractional catabolic rates were highly significantly 
greater than the corresponding synthesis rates (Table VI). 
(iii) Compared / ....•.... 
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(iii) Compared with the catabol ic rate in the untreated hypophysectomised 
rats. 
The absolute and fractional catabolic rates in the treated and untreated 
hypophysectomised rats were not significantly different on day 2 (Tables Ill and IV). 
On day 9 however, the absolute catabolic rate was highly significantly greater 
in the treated rats but there was no significant difference between the fractfonal 
catabolic rates on this day (Tables Ill and IV). 
(iv) Compared with the catabolic rate in the sham operated pair fed rats. 
Absolute and fractional rates in the growth hormone treated group were 
highly significantly less than those of the pair fed group on day 2. The same was 
true of the absolute rates on day 9, but there was no significant difference between 
the fractional rates on th is day. 
C. Albumin Concentration 
The albumin concentration fell sharply for the first four days after which 
there was a rise so that for the last four days of the study period, they lay with in 
the lower limit of normal. 
- 58-
CHAPTER FIVE 
DISCUSSION 
h I b . (13, 35, 40, 41 , 43, 51) h h h h It as ong een recogn 1sed t at t e ypop ysec-
tom ised rat voluntarily consumes less food than normal rats. Whilst the cause of 
this anorexia has not been determined with certainty, if inference from clinical 
experience with hypopituitary patients is permitted, it seems most I ikely that glu co-
corticoid deficiency is the underlying cause since this symptom is consistently 
abolished by cortisone treatment. Additional support for this contention comes 
from limited experiments conducted but not included in this thesis, in which corti-
costerone was administered in physiological doses to hypophysectomised rats and 
resulted in a marked improvement in the food intake. It would appear that growth 
hormone deficiency is not the responsible factor since no increase in food intake was 
observed when hypophysectomised rats were treated with growth hormone, 0 49) a 
finding which has been confirmed in these studies. Inadequate protein consumption 
may result in significant alterations in albumin metabolism and the interpretation of 
the data obtained in the untreated and growth hormone treated hypophysectomised 
rats must take into account the influence of the post hypophysectomy anorexia. 
Over the past decade numerous studies have focussed attention on the effects 
of altered dietary intake on albumin metabolism, from which much of our present day 
understanding of albumin homeostasis has been derived. Since many of the obser-
vations made in the experiments in the treated and untreated hypophysectomised rats 
can be explained in terms of principles es tab I ished in these nutritional studies, a 
discussion of the results of the pair feeding experiments will be presented first, along 
with a brief review of the relevant literature. 
I. PROTEIN DEPRIVATION AND ALBUMIN METABOLISM 
H lb • • . h . . f f k h" k (149 - 154) d ypoa ummaem1a 1s a c aracterist1c eature o was 10 or an 
is a reflection of the depletion of the total body albumin mass. Brock (l 55) and 
Waterlow (l 56 ) were agreed that significant hypoalbuminaemia occurred as a late 
event, and that considerable depletion of body protein could occur before the plasma 
albumin level/ ...........•• 
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albumin level was significantly reduced. 
When faced with an inadequate supply of dietary protein, losses of albumin 
occur from both the intra and extravascular compartments. Although methods for 
measuring the extravascular albumin mass are, in the strictest sense, only valid under 
• 0 0 h b d d di (101 I 157 - 159 ! 161 = 163) steady state cond rf'rons, rt as een emonstrate repeate y 
that when hypoalbuminaemia is produced by either dietary protein restriction or by 
plasmaphoresis, depletion of the extravascular mass exceeds that of the intravascular 
mass. Evidence was also presented in these studies to show that albumin had been 
transferred from the extravascular to intravascular compartments, and it was proposed 
that this transfer represented an adaptive response on the part of the body to maintain 
the intravascular albumin pool constant, albeit at the expense of the extravascular 
pool. Though initially such transfer might succeed in its purpose, ultimately in the 
face of continued insult, the intravascular albumin pool would also become depleted. 
It is therefore easy to conceive of a situation in which depletion of total body albumin 
might occur to some degree before a reduction in plasma albumin concentration ocurred, 
and such a situation was reproduced by Hoffenberg et al (l 6 l) by exposing adult sub-
jects to a low protein diet. 
Reduced rates of albumin catabolism are found in children suffering from 
k h. k (156, 158, 163 = 165) II . . I b· (161) • was ror or, as we as rn experrmenta su 1ects or an,-
1 (127, 160, 161, 166, 167) d d" I . · d h' mas expose to rets ow rn protein content, an t rs re-
duction in catabolic rate appears to be related to the state of depletion of the subject 
rather than to the protein intake at the time of measurement. For example, Hoffen-
berg et al (l 6 l) found that catabol ic rates in hypoalbuminaemic subjects were low 
despite the provision of a normal dietary intake. Kirsch et al (l 27) showed that 
when rats were acutely deprived of dietary protein the catabolic rate only fell 
approximately one week after the protein free diet was started. Conversely when 
these protein depleted rats were once again allowed to eat a diet containing normal 
levels of protein, catabolism did not increase immediately but some three or four 
days later. Comparable observations were made by James and Hay (163) who con-
ducted similar experiments in infants suffering from kwash iorkor. 
The evidence to suggest/ ...... . 
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The evidence to suggest that it is the size of the intravascular pool of 
albumin (reflecting as it does the state of depletion) that dictates the rate of 
catabolism, is compelling. Analbuminaemic subjects have abnormally low rates 
of catabol ism (l 69 ' l 70) which can be restored to normal if the intravascular 
pool is expanded by albumin infusion. (l 7l) Above normal rates of catabol ism 
b . d f lb •• f • ' · (1 68) bb' (1 72 ) d h 073 ) were o tame a ter a umm m us1ons m mice, ra its an umans. 
Conversely depletion of the intravascular pool by plasmaphoresis (l Ol' 161 ) caused 
a reduction in albumin catabolism, despite the provision of a normal diet. 
The elucidation of the behaviour of albumin synthesis in dietary depletion 
has been hindered by the absence of valid methods for measuring this process under 
nonsteady conditions, as was discussed in general terms in Chapter 2. "Synthesis 
. (166) . (161 ) plus transfer" rates were found to be low m rats and rabbits and humans 
on low protein diets. When protein was again made availablev albumin levels 
"d I I f h · h · · f d (1 58 ' 165) h • • · · f rose rap, y to norma , rom w 1c 1t was m erre t at m1t1at1on o 
cure was accompanied by a considerable increase in albumin synthesis. 
Recently changes in albumin synthesis have been measured directly. Hoffen-
berg, 042) Kirsch et al (l 27) and Rothschild et al (l 24) have used the 14c carbonate 
method and James and Hay (l 63) have used 131 1 label led albumin and a computer 
technique suitable for nonsteady conditions. Unlike albumin catabolism, with-
drawal of protein from the diet leads to a prompt reduction in albumin synthesis and 
repletion results in a rapid return to normal or even above normal levels. This be-
haviour strongly suggests that albumin synthesis is intimately related to the avail-
ability of substrate amino acids. 
The overall responses of albumin metabolism to protein deprivation and re-
pletion may therefore be summarised as fol lows: 
Withdrawal of dietary protein rapidly results in a reduction 
in albumin synthesis, and since catabolism within the intravascular 
compartment continues to proceed at normal rates, the intravascular 
albumin pool starts to contract. Increased transfer of albumin from 
the extravascular compartment might protect the intravascular com-
partment from depletion to an extent but, when the intravascular 
albumin/ ••...•........•••. 
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albumin mass shrinks to some critical level, catabol ism becomes 
reduced as an additional protective measure. When an adequate 
protein intake is again made available synthesis rapidly returns to 
normal levels and the intravascular albumin pool is gradually ex-
panded until such time as the compensatory reduction in catabolic 
rate is no longer required. 
Discussion of the results of the pair feeding experiments. 
(i) SYNTHESIS RATE 
As was anticipated the pair feeding experiments resulted in changes in al-
bumin metabolism. During the first two days of the experimental period the food 
intake was severely restricted, the rats being provided with an average of only 3 g. 
of food, which virtually amounted to a total fast. The mean absolute synthesis rate 
on day 2 was 32% less than the mean normal value, and this fall represented a highly 
significant reduction. Though the mean fractional synthesis rate was 19% less than 
the mean normal, this represented a change that was at best only probably significant. 
Kirsch et al (l 27) showed that the absolute synthesis rate became significantly 
reduced after approximately six days of protein deprivation. Those findings and the 
present are not strictly comparable however since in the present study the rats were 
fed a normal diet in reduced quantities, whereas in the former study the protein free 
diet was made isocaloric on a weight basis with a normal diet, and ad libitum feeding 
was permitted. Under such circumstances one might anticipate a protein sparing 
action of carbohydrate. 
Rothschi Id et al (l 24) have studied the effect on albumin synthesis of an 
eighteen to thirty-six hour fast in rabbits. After this time interval the absolute 
synthesis rate was found to be reduced by 33%. Fractional synthesis rates were 
not provided but since body weight, plasma volume and plasma albumin concentration 
were virtually unchanged before and after the fast, the reduction in synthesis rate 
must have been due almost entirely to a lowered fractional rate. In the present 
studies absolute synthesis was reduced by an almost identical amount as that ob-
served by Rothschild but the reduction in fractional rate was less marked. The 
greater fall / ....... , , .. , . , , , 
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The greater fol I in absolute than fractional synthesis rates when compared with 
normal values was due to the presence of a reduced intravascular albumin pool 
in the experimental rats. Contraction of the pool size resulted from the com-
bined effects of the sham operation and food restriction causing marked body weight 
loss and a smaller plasma volume. Thus, four of the six batches studied had plasma 
volumes that fel I outside the range of the normal rats, but the albumin concentration 
remained within the normal range in al I. 
The present study, as wel I as that of Rothsch i Id et al, (l 24) not only con-
firms the well established finding of reduced albumin synthesis when dietary protein 
is inadequate, but demonstrates the rapidity with which this reduction can occur. 
Whilst the basic defect is clearly a lack of substrate amino acids in the diet, 
Rothschild et al (l 24) also showed that some change, as evidenced by reduced 
amino acid incorporating ability, occured in the microsomes of liver parenchymal 
cells of the fasted rabbits. Korner (l 74 ) however in an earlier study was unable 
to show this effect in the rat liver cell free system after an eighteen hour fast. 
After day 2 the food intake increased progressively, though stil I remaining 
well below the normal range. Synthesis rates remained low until day 9, by which 
time sufficient food was being provided to maintain normal fractional synthesis rates 
in three of the six batches studied. As a group the fractional synthesis rates on 
day 9 were not significantly different from normal though the absolute synthesis 
rates were. This difference in significance is again explained by the smaller 
size of the experimental animals compared to the normal controls. 
Kirsch et al (l 27) and James and Hay (163 ) have clearly demonstrated that 
normal synthesis rates can be re-established as rapidly as twenty-four hours after 
the provision of adequate amounts of dietary protein, and a similar rapid response 
has been shown here when the food intake was increased in the latter half of the 
study period. There is clearly individual variation in the amount of food needed 
to support normal synthesis rates, since only three of the six batches consuming larger 
quantities of food on day 9 had normal fractional synthesis rates, whilst one of the 
two batches on day 6 had a normal rate despite a smaller food intake. 
(ii) Catabolic Rate/ ...... 
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(ii) CATABOLIC RATE 
Apart from a highly significant rise on day 2, absolute and fractional cata-
bol ic rates remained with in normal I imits throughout the study period. The relation 
between the introvascular pool size and the albumin catabolic rate was discussed on 
page 60. In terms of this relationship the presence of the normal catabolic rate 
(apart from the post-operative rise) indicates that the intravascular pool had not 
been compromised sufficiently (as reflected by the normal albumin concentration) by 
reduced synthesis to require the compensatory reduction in catabol ism. 
The nature of the post-operative rise in catabol ism. 
Tissue injury, for example burns, fractures and surgical operation results in 
a number of biochemical responses. Negative nitrogen balance and hypoalbumin-
aemia are two such responses. Increased rates of albumin catabolism have been 
demonstrated after fractures (l 75) and burns, (l 75 ' 176) and post-operative I y. (176 - 178) 
Though increased rates of catabolism have been convincingly demonstrated, exudation 
of albumin into wounds (and in particular burns) may contribute to a variable extent 
to the increased rate of elimination of albumin from the intravascular pool. (1 76 , 179' 
180) 
Similarities between the biochemical responses post-operatively and after 
administration of glucocorticoids initially prompted the measurement of glucocorticoid 
activity in patients suffering tissue injury or undergoing surgery. Raised urine and 
plasma 17 hydroxycorticosteroids have been demonstrated in a wide variety of con-
d. • (182 - 184, 186 - 189) d h . I • h h 11 11 1t1ons, an t e rise appears to corre ate wit t e stress to 
which the patient is exposed. In uncomplicated surgery raised 17 hydroxycorticos-
teroid levels exist for twelve to twenty-four hours (1841 1871 188) whilst in bums the 
elevation may persist for a week or longer. (185) In view of the ability of gluco-
corticoids to stimulate albumin catabol ism in experimental (l 32 , l 90) or naturally 
(191 , 192) • • • • f I • f • 
occurmg s1tuat1ons, a sat1s actory exp anat1on to account or increased 
albumin catabolism would be on the basis of raised glucocorticoid activity. Cuth-
bertson (l 8l) has reviewed the evidence and has concluded that increased adreno-
cortical secretion is clearly involved but that this is not the sole mediator of the 
metabo I ic / ............ . 
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metabolic response to inj'-'ry. 
Glucocorticoid levels were not measured in the sham operated pair fed rats. 
If it is assumed that the raised levels of albumin catabolism coincide with elevated 
glucocorticoid levels, then a twenty-four to forty-eight hour post-operative adreno-
cortical response would have occured, and this would agree with the magnitude of the 
response shown by other workers after uncomplicated surgery. Retention of radio-
iodide in the body water which could have resulted in spuriously high values for 
catabolism, was excluded by measuring T.C.A. precipitable activity in the plasma. 
No excess unbound activity was demonstrated in the plasma, and neither was there 
any wound infection or oedema into which labelled albumin may have been exuded, 
so that it may be accepted that the high post-operative values were due to a true 
increase in catabolism. That this increase was mediated at least in part by raised 
glucocorticoid activity is unproven, but appears to be likely in view of the much 
smaller post-operative response exhibited by the hypophysectomised rats in which 
the pituitary-adrenal axis was disrupted and continued adrenocorticoid function 
prevented. 
11. HYPOPHYSECTOMY AND ALBUMIN METABOLISM 
The earlier experimental work which was reviewed in Chapter l demonstrated 
conclusively that significant reductions in plasma albumin levels ocurred after hypo-
physectomy, and furthermore showed that a true reduction in intravascular albumin 
mass ocur red. These results whilst consistent and convincing were of limited value 
since the underlying changes in synthesis or catabolism could not be defined. Ulrich 
and coworkers (5 l) were the first to provide such information. A tracer dose of 35s 
labelled albumin was administered to albino rats two weeks after hypophysectomy and 
the plasma albumin specific activity measured over the next seven days. Using a 
kinetic model based essentially on the slope of the plasma specific curve, these 
workers deduced that after hypophysectomy a fall in synthesis rate occured initially 
followed by a fall in catabolism, and that the albumin "replacement rate" was approxi-
mately half that of normal rats. Because of the assumptions introduced by the authors 
when considering their data, this study offers some difficulty in interpretation. In 
the first instance it was assumed that synthesis and catabol ism comprised a single 
process and on I y / ........... . 
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process and only a net change in 11 synthesis-catabolism 11 could be determined. 
Secondly the authors assumed steady state conditions to have prevailed during the 
experiment, which it was conceded by them, in view of the rapid weight loss evi-
denced by the animals could not have obtained. From the general considerations 
presented in Chapter 2 it wi 11 be rec al led that turnover data derived from the slope 
of the plasma specific activity curve alone fails to take into account specific activity 
differences between intra and extravascular compartments. The kinetic model em-
ployed in this study is therefore clearly inappropriate and the difficulty in interpreting 
this data is compounded by the use of an isotopic label that is subject to a degree of 
re-uti I isation. 
The only other study where the kinetic behaviour of albumin after hyphysec-
tomy has been investigated is the clinical study of Jeejeebhoy et al, (52) who used 
radio iodinated albumin to measure albumin catabol ism and "synthesis plus transfer" 
in hypopituitary subjects, and found that three of four cases studied had values for 
these processes below the normal control range. This study whilst providing re-
presentative values for catabolism, only provides an approximate value for synthesis. 
As was emphasised in Chapter 2, the study of iodinated albumin preparations can 
never supply direct information about rates of albumin synthesis. It should alS'O be 
mentioned that all of the cases studied were on some form of hormonal substitution 
therapy (exclusive of growth hormone) and the results obtained may not truly reflect 
the state in the untreated hypopituitary subject. 
The results of the experiments conducted in this thesis provide the first in-
formation regarding the effect of hypophysectomy on albumin synthesis and catabolism 
when these processes are measured directly and independently of each other. 
Discussion of the results of the hypophysectomy experiments: 
(i) SYNTHESIS RATE 
Compared with normal values, hypophysectomy resulted in an early and striking 
reduction in both absolute and fractional synthesis rates, and a further significant re-
duction occurred at the end of the study period: The reduction in synthesis rate may 
have resulted from the single or combined effects of (a) a deficiency of one or more 
of the pituitary hormones and (b) the reduction in food intake. 
(a) There is a/ •......•.•. 
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(a) There is a paucity of data relating to the role of pituitary hormones 
in albumin synthesis. That relating to growth hormone has been discussed in Chapter 
l and will be returned to in greater detail later in this chapter. Synthetic analogues 
of androgens have not been shown to have any effect on albumin metabolism. (l 3 l, 196) 
• (132 190- 192) • (130 193 - 195) Adrenocort,cal ' and thyroid ' hormones have been 
shown to increase albumin catabolism 1 in vivo•, and since the total amount of albumin 
estimated to have been catabolised was greater than the amount by which the total 
body albumin mass was reduced, it was concluded that albumin synthesis had increased 
to compensate for the increased catabolism. That synthesis was stimulated directly was 
not ascertained, and the ability of glucocorticoids and thyroid hormones to stimulate 
albumin synthesis remains to be demonstrated by direct measurement. To date no such 
measurements have been reported. Further discussion of the possible role of pituitary 
hormones in albumin synthesis will be undertaken when the effects of growth hormone 
treatment are presented. 
(b) On day 2 there was no significant difference between the fractional 
synthesis rates of the hypophysectomised rats and that of th~ pair fed rats so that the 
immediate effect after hypophysectomy was no greater than could be accounted for 
by a reduced food intake. However, at the end of the study period clearcut differences 
manifested. Whereas the sham operated rats when fed larger quantities of food im-
mediately responded by restoring albumin synthesis to normal rates, the hypophysec-
tomised rats displayed a further significant fall and the differences in synthesis rate 
between the two groups of rats on day 9 became highly significant. On day 9 there-
fore the reduction in synthesis rate was greater than would be expected on the basis 
of a reduced food intake, and pituitary insufficiency was clearly contributory. The 
probable nature of this insufficiency will be discussed later in this chapter. 
Prior to embarking on this project it was thought that after hypophysectomy the 
synthesis rate would fall more rapidly than after sham operation, for after the latter the 
pituitary anabolic hormones would sti II be present - that was of course at that time 
assuming that the pituitary gland did indeed participate in albumin synthesis. This 
has not been borne out by the results of the experiments since the fol I in synthesis rate in 
the first two days/ •.......••• 
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the first two days after hypophysectomy was as rapid and as great as that after 
fasting, so that the presence of the pituitary gland confers no particular ad-
vantage on the individual in the face of protein depletion. What has become 
apparent however is that the pituitary gland is important for the restoration of 
normal rates of synthesis during the process of repletion. In the face of a larger 
food intake the sham operated but not the hypophysectomised rats were able to 
synthesise albumin at normal rates. It seems reasonable to suggest therefore that 
the rapid return to normal levels of albumin synthesis observed by Kirsch et al O 27) 
and James and Hay (163) after protein repletion, is a response for which an intact 
and functioning pituitary gland is required. 
In view of the continued fol I in synthesis rate despite the larger food in-
take, one must ask if the hypophysectomised rat is able to utilise any of the food 
it eats. The issue is largely speculative but it should be noted that Levin (37) was 
unable to cause growth or to establish positive nitrogen balance when hypophysec-
tomised rats were force fed normal quantities of food. 
(ii) CATABOLIC RATE 
The post-operative rise in catabolism on day 2 was evident only in the frac-
tional rate, since the rapidly falling albumin concentration obscured this response 
when the catabolic rate was expressed in absolute terms. The post-operative re-
sponse in the hypophysectomised rats was significantly less .than in the sham operated 
rats, confirming that the pituitary gland plays an integral part in the post-operative 
rise in albumin catabolism. Although significantly less than the pair fed rats, the 
fractional catabolic rate on day 2 in the hypophysectomised rats was still signifi-
cantly greater than normal. This more moderate response presumably reflects the 
effects of only ten to fifteen minutes of anaesthesia and surgery prior to removal of 
the pituitary gland whilst continued pituitary function remained possible in the sham 
operated rats. 
For the fall in the catabolic rate at the end of the study period two possible 
explanations present themselves:-
(l ) Absence of/ •........ 
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(l) Absence of pHuitary hormones. 
Adrenocortical (l 32 , l 90- l 92) and thyroid (l 30, l 93 - 195) hormones have 
been shown to increase albumin catabolism. It becomes possible to argue therefore 
that catabolism would be decreased once these hormones disappeared after hypophy--
sectomy. For th is reason corticosterone levels were measured in the plasma after 
hypophysectomy. Complete disappearance had occurred with in forty-eight hours, 
whereas the fall in catabolism only occurred three to four days later. If plasma 
corticosterone levels may be taken as correlating wHh their biological effect in 
general (and from clinical experience this assumption appears to be largely justified) 
then the reduction in catabolism cannot be ascribed to the disappearance of gluco-
corticoids. 
Similar measurements of thyroid hormones were not undertaken. Clinical 
experience has shown that the effects of circulating thyroid hormones take some days 
to wear off. The possibility that the reduction in catabolism was due to a reduction 
in thyroid hormone action some days after hyRophysectomy j cannot therefore be ex-
cluded. 
(2) Reduction in albumin intravascular pool. 
Marked reductions in the intravascular pool size occurred as a result of the 
profoundly reduced synthesis rate, and is reflected by the lowered plasma albumin 
concentration. The compensatory reduction in catabolism would occur in response 
to a decreased intravascular pool irrespective of the pathogenesis. Since however 
the decreased diet was not sufficient to reduce catabolism in the sham operated rats, 
reduction in catabolism in the hypophysectomised rats may be ascribed to hypo-
pituitarism causing decreased synthesis and consequently a reduced intravascular pool. 
Ill GROWTH HORMONE AND ALBUMIN METABOLISM 
It is clear from the review of the literature presented in Chapter l that there 
is considerable conflict of opinion as to the role played by growth hormone in regu-
lating albumin metabolism. Administration of growth hormone to intact animals had 
l·ttl ff t h lb • • (53 - 55) b d • • , e or no e ec on t e a umm concentration ut cause an increase m 
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the intravascular pool size. (53 ) In hypophysectomised animals growth hormone 
had little (45) or no effect (49 , 50) on restoring lowered albumin levels to normal. 
Although in one study (50) growth hormone was able to restore the intravascular pool 
to its normal size, the fact that the growth hormone preparation used was heavily 
contaminated with other pituitary hormones must cast some doubt on the validity of 
the resu I ts. 
As far as the dynamic effects of growth hormone on albumin metabolism are 
concerned, the picture is as confusing. The only two studies which have endeavoured 
to clarify this aspect in hypophysectomised subjects are those of Ulrich et al (5l) and 
Jeejeebhoy et al. (52) These two studies were evaluated when considering the re-
sults these workers obtained after hypophysectomy, and the same criticisms levelled 
there are also applicable to the observations made after growth hormone replacement 
therapy. It was shown by Ulrich et al that treatment with growth hormone resulted 
in a steeper plasma albumin specific activity curve and an increase in the body albumin 
pool. The albumin "replacement rate" was nearly three times that of the untreated 
hypophysectomised rats, and these findings were interpreted to mean that growth hor-
mone caused an increase in albumin synthesis. On the other hand Jeejeebhoy et al 
found that the "synthesis plus transfer" and catabolic rates already low in hypopituitary 
,\lumans were further decreased when growth hormone was administered, and it was 
suggested by these workers that growth hormone achieved its effect by decreasing 
albumin catabolism rather than by increasing its synthesis. These findings raise the 
important question as to whether growth hormone is anabolic or anti-cataqolic in 
respect of albumin metabolism and attention will be paid to this point on page 74. 
Experimentation with growth hormone in intact subjects has also led to con-
flicting results. Gabuzda et al (57) attempted the separate measurement of albumin 
synthesis and catabolism after the injection of 131 1 labelled albumin in four humans 
with clinical and biochemical evidence of hepatic cirrhosis. The difficulties of this 
form of measurement have already been outlined and interpretation is furthermore 
made difficult by the choice of subjects with abnormal liver function. From 
the data obtained the authors concluded, as had Jeejeebhoy, that growth hormone 
reduced albumin/ •. , .... , . 
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reduced albumin catabolism but had no effect on synthesis. Gross et al (56) 
believed that growth hormone had no effect on either synthesis or catabol ism but 
postulated that under the conditions of their experiment, growth hormone raised 
the plasma albumin concentration by altering capillary permeability in such a way 
as to reduce the outflow of albumin from intravascular to extravascular compartments. 
The only study where albumin synthesis has been measured directly by the 14c car-
bonate method, is an 'in vitro' study undertaken by Sellers et al (59) using a perfused 
rat I iver. In th is way a 33% increase in synthesis rate was demonstrated if the 
donor rats were pretreated with growth hormone. 
Discussion of the growth hormone replacement experiments. 
(i) SYNTHES IS RATE. 
The present experiments provide the first demonstration of the ability of 
growth hormone to stimulate albumin synthesis 'in vivo' when measured directly. 
Both at the beginning and the end of the study period absolute and fractional syn-
thesis rates in the growth hormone treated rats were significantly higher than those 
of the untreated rats, the latter proven by immunoassay to be growth hormone de-
ficient. However, despite this ability to stimulate albumin synthesis the values 
obtained were sti II significantly less than normal and a consideration of the 
reasons why normal values were not obtained is warranted. 
In the first instance it was observed that growth hormone had no significant 
effect on the post hypophysectomy anorexia and as a result the food intake was still 
considerably less than normal. Under these circumstances therefore the best effect 
growth hormone could be expected to achieve, would be to increase the synthesis 
rate to the level of the pair fed rats. On day 2 this effect was achieved and the 
values obtained in the two groups were not significantly different. One may con-
clude therefore that on day 2 the decreased food intake alone was preventing the 
restoration of normal synthesis rate levels. On day 9 however the picture was 
different. Despite the progressive increase in food intake synthesis rates fell 
throughout the study period. In the face of th is increased food intake the syn-
thesis rate in the sham operated rats rose, but fell in the growth hormone treated 
rats, and the difference between the two groups became significant. The fall in 
synthesis rate/ •........... 
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synthesis rate in the face of both an increase in food intake and the wherewithal! 
to synthesise albumin (viz. growth hormone) clearly implicates the participation of 
other factors in the regulation of the synthetic process. The possible participation 
of other pituitary hormones requires to be considered. 
(a) Glucocorticoids: 
The albumin catabolic effect of glucocorticoids is well recognised, but there 
is also evidence to suggest that these hormones may play a part in regulating albumin 
synthesis. The administration of glucocorticoids stimulates the catabolism of extra-
h . ( ) . (197 - l 99) d . d f . . b I epat1c carcass protein an in uces a state o negative nitrogen a once 
in the body as a whole. The loss of protein does not affect the entire body for under 
these conditions the viscera (liver and gut) retain or increase their weight, protein 
and RNA content. (l 97 - 200) These findings have been interpreted (l 99 ' 201 ' 202) 
to mean that glucocorticoids cause a flow of amino acids from carcass to liver. Thoug, 
most of the amino acids arriving at the liver are destined ~or gluconeogenesis, , 
Korner (202) believes that with the flooding of the liver with amino acids any s~rplus 
will be used for protein synthesis. This belief conceives of glucocorticoids playing 
a passive role in protein synthesis by providing a supply of amino acids to the liver 
from which protein wil I be synthesised under the influence of the protein anabolic 
hormones. Growth hormone on the other hand appears to have an opposite effect 
b f ' h d '. f · · I h f 1· • (2D4- 206) y avouring t e epos1t1on o protein in muse e, at t e expense o 1ver protein. 
A more specific stimulus to protein synthesis appears likely in view of the ob-
servation of Korner (202) that cortisol enhances the ability of liver microsomes to in-
corporate amino acids into protein 'in vitro', and Bancroft et al (2o3) have recently 
sho~n that hydrocortisone caused a fourfold increase in the rate of albumin production 
in an albumin producing hepatic cell culture system. 
The above evidence makes it possible to offer some explanation for the incom-
plete restoration of albumin synthesis rates in the hypophysectomised rats receiving only 
growth hormone treatment. The absence of glucocorticoids deprives the liver of a 
direct stimulus to albumin synthesis, as wel I as depriving it of an endogenous supply of 
substrate amino acids from carcass protein. Furthermore in the absence of the counter-
acting influence/ .•.......... 
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acting influence of glucocorticoids, the growth hormone given to the hypophy-
sectomised rat would tend to cause a predominant shift of endogenous and dietary 
amino acids away from liver to muscle, thus further depriving the liver of amino 
acids for albumin synthesis. 
(b) Thyroid hormones: 
What has been said for glucocorticoids appears to be applicable to thyroid 
hormones. With thyroid treatment liver weight, protein and RNA content gains 
at the expense of that of carcass muscle, (206, 207) again suggesting that the liver 
is responding to an increased flow of amino acids coming from the breqkdown of 
. H . . (208-212)h d d carcass protein. owever many investigators ave emonstrate a 
stimulation by thyroid hormones of some of the intracellular events usually associa-
ted with protein synthesis (inc.rsased amino acid uptake, shift of polysome profile 
to heavier aggregates, increased RNA synthesis), and the appearance of albumin 
in the plasma of the tadpole during metamorphosis may be induced by treatment 
with thyroid hormones, (2 l 3) so that it appears that the response of I iver protein 
metabolism after thyroid hormone treatment is not explicable only in terms of a 
passive response to an increased amino acid supply from the carcass. These ob-
servations however do no more than reflect liver protein synthesis as a whole. 
Whether albumin production is increased remains as yet undetermined. 
In their own right thyroid hormones are essential for normal growth and 
development. It is also well known that normal thyroid function is necessary 
for the optimal expression of growth hormone. In the growth hormone treated 
rats therefore incomplete growth hormone effect might also have been due to the 
absence of the augmenting action of the thyroid hormones. 
Finally, the diminishing effect of growth hormone treatment on albumin syn-
thesis may have been due to the development of antibodies to bovine growth hormone, 
although there is little likelihood of this having occurred during the short space of 
nine days. There is I ittle doubt that the growth hormone preparation used was bio-
logically active since the magnitude of the post hypophysectomy weight loss was 
less, and blood urea levels were considerably lower than in hypophysectomised rats. 
Furthermore/ ........•... 
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Furthermore, this same preparation was shown by the National Institutes of Health 
to cause the resumption of growth in young hypaphysectomised rats. 
(ii) CAT ABO LIC RATE. 
As in the untreated hypophysectomised rats the past operative rise in cata-
bolic rate was evident only in the fractional rate, being obscured by the falling al-
bumin concentration when expressed in absolute terms. This response was signifi-
cantly less than that of the sham operated rats, and not significantly different from 
that in the untreated hypaphysectomised rats. 
The subsequent fol I in catabol ic rate was I ess pronounced than that shown by 
the untreated hypophysectomised rats. Because the synthesis rate fell less slowly 
after growth hormone treatment the intravascular pool would tend to become de-
pleted at a later stage and hence the compensatory reduction in catabol ism would 
also be delayed. The presence of normal catabolic rates for a full seven or eight 
days after hypophysectomy strongly suggests that pituitary hormones are not essential 
for the maintenance of normal catabol ic rates. 
It is difficult to provide an explanation for the fall in albumin concentration 
in the growth hormone treated rats, since the concentration falls at a time when the 
synthesis rate is at its highest and rises when the synthesis rate falls. The d-isparity 
between lhe synthesis and catabolic rates cannot account for the reduced concen-
tration. Since the synthesis rates in the growth hormone treated and sham operated 
rats were no different on day 2 and the latter showed no fall in concentration, it 
would seem that the decreased concentration is probably the result of some temporary 
disturbance of albumin distribution, though the exact nature of this is difficult to 
understand. Direct measurements of the plasma volume have .. excluded the possibility 
of plasma volume expansion causing the hypoalbuminaemia. Arising out of this ob-
servation is the possibility that the decreased albumin concentration after hypophy-
sectomy (which was of the same magnitude as the hypaphysectomised rats receiving 
growth hormone) may also be due in part to altered albumin distribution. 
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MODE OF ACTION OF GROWTH HORMONE 
(a) Albumin anabolic or anti-catabol ic? 
Hypophysectomy results in an immediate cessation of growth and treatment 
with suitable preparations of growth hormone causes growth to be resumed. How-
ever one chooses to define growth it is clear that protein synthesis is intimaf·ely con-
cerned in the process. In Chapter l earlier evidence was cited in which growth hor~ 
mone treatment was found to lower plasma amino acid levels, to diminish urinary 
nitrogen excretion and increase the proportion of protein in the tissues. In view 
of the dynamic nature of the processes involved in protein metabolism, the increase 
in protein content of the tissues could have arisen from an increase in protein syn-
thesis or a reduction in protein catabol ism. A consideration of the evidence re-
lating to the effect of growth hormone on total body protein turnover falls outside 
the scope of this thesis suffice it to say that much of the evidence (see references 
144, and 214 for review) is as conflicting as that relating to albumin metabolism in 
which anabolic and anti-catabolic actions have been proposed. 
In the present study treatment with growth hormone was shown to result in 
higher rates of both albumin synthesis and catabolism when compared with untreated 
hypophysectomised rats, and this latter finding contrasts with the results of those 
workers who found that growth hormone lowered albumin catabol ism. On grounds 
of commonsense alone it seems highly unlikely that growth hormone could regulate 
albumin levels effectively if under its influence both synthesis and catabolism were 
raised simultaneously. It is more reasonable to propose that the action of growth 
hormone is to stimulate albumin synthesis. This will result in more albumin entering 
the intravascular pool, the size of which in turn will dictate the rate at which cata-
bolism is to proceed. In this way growth hormone would effect albumin synthesis 
primarily, and its effect on catabolism would be secondary by virtue of its ability 
to influence the size of the intravascular pool. 
It seems reasonable to extend this proposal to include all the other hormones 
which stimulate albumin synthesis. Were this the case then albumin synthesis alone 
would be controlled/ ••...... 
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would be control led on a hormonal basis and catabol ism would respond appropriately 
to any change in the intravascular pool size that had been brought about by changes 
in the synthetic process. In an attempt to demonstrate the existence of such a homeo-
static mechanism a number of hypophysectomised rats were infused with albumin and 
the catabolic rate measured. It was anticipated that synthesis rates would be low 
because of the combined effects of the absence of pituitary hormones and inadequate 
diet, but catabol ism would proceed at normal rates because the intravascular pool 
was being maintained artifically by the albumin infusions. The results of these 
experiments were disappointing to say the least. The hypophysectomised rat is 
clearly unable to withstand the repeated stresses of daily albumin infusions, and 
many rats succumbed to minor allergic reactions. Hypervolaemia· may also have con-
tributed to the alarming mortality rate since the rats were infused daily with large 
doses of albumin (150- 200 mg), and in the absence of corticosterone, free water 
clearance is reduced and the ability to deal with a fluid load is impaired. In the 
few rats that did survive, daily albumin infusions given in a dose sufficient to main-
tain the intravascular pool within normal limits, and in the absence of proteinuria, 
maintained the catabolic rate at the upper limit of normal for five or six days after 
it would usually have been significantly reduced after hypophysectomy. Unfor-
tunately for technical reasons no synthesis rate values were obtained. This experi-
mental approach offers hope of further clarifying the role of the anterior pituitary 
hormones in albumin metabolism, but is beset with formidable obstacles. 
If then it is possible for albumin catabolism to proceed at normal rates with-
out the direct action of the pituitary gland, reconciliation with the known albumin 
catabol ic effects of adrenocortical and thyroid hormones is necessary. The issue is 
largely speculative but it seems reasonable to suggest that under normal circumstances 
the size of the intravascular albumin mass controls the catabol ic rate as a specific 
control mechanism, whilst the ability of glucocorticoids and thyroid hormones to 
stimulate albumin catabolism is merely one of their numerous and widespread actions, 
which under conditions of hypersecretion may result in excessive albumin catabolism. 
The central role of the intravascular pool in controlling catabolism is conceptually 
satisfying. That catabolism proceeds as a first order process geared to the size of 
the intravascular albumin pool is generally held to be true, although under certain patho-
logical conditions/ ...........• 
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I • I d. . ( • . I (233) I (234 - 236) d d O (190)) og1ca con 1t1ons gastrorntestrna , rena an en ocnne 
this first order relationship may not hold since high rates of catabolism may exist 
in the presence of a reduced intravascular pool. 
(b) Can growth hormone exert its protein anabolic effect on liver directly? 
Young has long held the view that growth hormone achieves its anabolic 
(nitrogen retaining) properties by stimulating the secretion of insulin from the pan-
creas, which is held by him to be the protein anabolic hormone, and detailed re-
• . (33 215 217) views of the relevant I 1terature have been presented ' ' • Later after 
it was shown that growth hormone did not stimulate the release of insulin from rabbit 
pancreas (21.8), it was suggested that growth hormone stimulated the release of in-
sulin bound in some inactive form to muscle. (233) The administration of growth 
hormone evokes a rise in plasma non esterified fatty acids (219 ' 220) and with the 
observation that this rise in fatty acids inhibits the peripheral utilisation of glu-
(221) · I · • ·bl · h • h h h cose rn muse e 1t remains poss1 e to retain t e suggestion t at growt or-
mone acts by stimulating insulin secretion. Thus it has been proposed (222) that 
growth hormone stimulates lipolysis, the resultant increase in plasma free fatty 
acids inhibits the peripheral utilisation of glucose thereby causing a rise in blood 
glucose levels which in turn triggers the secretion of insulin. Insulin has un-
doubted anabolic properties (see ref 224 for review) and insulin treatment in-
creases (224) and al loxan diabetes reduces (225) the microsomal incorporation of 
amino acids into protein in the liver cell free system. Yet Jefferson and Korner (226) 
using a perfused liver system have produced evidence that growth hormone can stimu-
late protein anabolism in the liver directly and without the mediation of insulin. 
However 'in vivo' the possibility cannot be excluded that part of the effects of 
growth hormone treatment are mediated by insulin. 
(c) Intracellular action of growth hormone. 
The exact mechanism (mechanisms) by means of which growth hormone achieves 
its undoubted protein anabolic properties to a large extent remains unsolved. Growth 
hormone increases amino acid uptake into cells (228) and stimulates the ability of 
• t • • .d • • (174, 227) b h . .d m1crosomes o incorporate ammo ac1 s into protein ut t ere 1s ev1 ence 
to both support and refute the suggestion that its action is at a genetic level. A 
consideration of th is field of investigation fal Is outside the scope of th is' thesis {see 
refs. 229 - 232 for extensive reviews). 
The results of/ •..........•. 
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The results of the experiments conducted in this thesis have shown that 
hypophysectomy reduces and growth hormone partially restores, both albumin syn-
thesis and catabolic rotes, and further that these changes cannot be explained on 
the basis of a reduction in food intake alone. The growth hormone data presented 
has been explained by proposing that the action of this hormone is primarily to 
stimulate albumin synthesis and that catabolism is affected through secondary alterations 
in the intravascular albumin mass. This proposal though in itself reasonable and in-
deed conceptually satisfying, provides neither an immediate nor a complete answer as 
to how albumin homeostasis is achieved on a day to day basis. It is clear from the 
large volume of experimental evidence that has accrued over the past fifteen or 
twenty years, that the mechanisms by means of which albumin metabolism is controlled 
cannot be explained simply. Normal albumin synthesis and catabolism is contingent 
upon the presence of on adequate supply of amino acids and upon normal gastrointes-
tinal and hepatic function. Also these processes ore influenced by the distribution 
of albumin between the intro and extravascular spaces and by the actions of a number 
of hormones. 
The results of the present experiments led to the suggestion that, in health 
at least, albumin synthesis might be controlled by hormones alone, whilst catabolism 
would be effected by a mechanism dependent on the intravascular albumin mass. 
Clearly this explanation is too simple. Each of the hormones proven or presumed to 
be capable of stimulating albumin synthesis has numerous other actions. One needs 
to contemplate the consequences on albumin synthesis if there is a cal I to hyper-
secretion of a hormone in order to effect some other metabolic adf ustment. For 
instance, would the rise in growth hormone in response to hypoglycaemia result in 
a parallel stimulation of albumin synthesis? It seems likely that a more specific 
system exists in order to prevent unnecessary albumin synthesis. The colloid osmotic 
pressure in the hepatic interstitium may be such a mechanism. Although Tav,ill 
et al (l 20) and Hoffenberg (l 42) were unable to depress albumin synthesis after albumin 
infusions, Rothschild showed that albumin synthesis was decreased after infusions of 
both albumin (237) and dextron. (l 37) Growth hormone or ACTH secreted in order 
to perform some other metabolic function might in some way be 'blocked' in the liver 
and prevented from stimulating albumin synthesis by the presence of a normal hepatic 
colloid osmotic/ •........•. 
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colloid osmotic pressure when the body albumin mass was normal. One may 
speculate that a fall in colloid osmotic pressure when the albumin mass was 
being compromised for one or other reason, might serve as a stimulus to the 
secretion of the albumin anabolic hormones. 
In disease states the picture becomes perplexing. Synthesis and catabolism 
wi 11 of course be affected if severe enough by disease of any of the viscera re-
sponsible for these processes, but in addition disease of the endocrine glands, as 
well as of those viscera responsible for the degradation and elimination of their 
hormones, may be of consequence for albumin metabolism. The nature of the 
changes in synthesis and catabolism wi 11 of course depend on the particular patholgy, 
as will the nature of the adaptive changes in albumin metabolism. Clearly a number 
of different responses are possible according to the disease, and the plethora of 
events may be impossible to unravel. 
Discussion has been largely restricted to a consideration of the hormonal 
control of albumin metabolism. The interactions of the endocrine system and the 
widespread and multiple effects on intermediary metabolism,. which in turn may 
give to secondary responses, prevent the formulation of any rigid unitary hypo-
thesis. It is of course tempting to explain the action of hormones in simple terms, 
and indeed Korner (222) has wryly commented on the psychological need to do so. 
The available evidence does not justify the occupation of this rather more comfort-
able position. 
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CHAPTER 6 
SUMMARY 
This thesis investigates the role of the anterior pituitary gland, and of growth 
hormone in particular 1 in regulating albumin metabolism. 
In order to gain historical perspective, Chapter l was devoted to a brief re-
view of earlier I iterature. The first half of the chapter was concerned with a review 
of the work which first suggested and later confirmed the integral role of the pituitary 
gland in the regulation of body growth. The potent growth promoting properties of 
the pituitary gland came to be identified with a factor named simply pituitary growth 
hormone, and further experimentation clearly implicated this hormone in the regu-
lation of protein metabolism. Plasma albumin was the particular body protein chosen 
for study in this thesis, and the second half of the chapter was devoted to a review of 
the effects that hypophysectomy and hypophysectomy and growth hormone replacement 
therapy have been shown to have on albumin metabolism. Earlier workers demon-
strated clearly that hypoalbuminaemia was a regular consequence of hypophysectomy, 
but studies designed to define the underlying changes in the synthesis and catabolism 
of this protein were few and contradictory. The role of growth hormone in albumin 
metabolism had been investigated in both hypophysectomised and intact subjects and 
these studies were wholly inconclusive. Growth hormone was shown to have little 
or no effect on plasma albumin levels, and when kinetic studies were undertaken 
some investigators claimed that the action of this hormone was to stimulate anabolism 
whilst others believed it to reduce catabolism. 
Chapter 2 presented a general account of the principal methods employed in 
this thesis viz. hypophysectomy, tracer labelling of plasma albumin and the measure-
ment of albumin catabolism_and synthesis. Less commonly used methods of hypophy-
sectomy were briefly described but details of the parapharyngeal method, that used 
in the present study, was deferred and is presented in the Appendix. Tracer labelling 
of plasma albumin was achieved by using 1251odine or 131 Iodine. Particular emphasis 
was placed on describing the conditions that have to be met for reliable labelling of 
plasma albumin, and tests of the satisfactory biological behaviour of the tracer "in 
• 11/ VIVO/ • •• , •••• , ••• , 
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vivo" were described. Details of the actual technique of labelling are presented in 
the Appendix. 
The various methods of measuring albumin catabol ism were next described, 
together with a brief account of the compartmental systems through which albumin is 
believed by various workers to be distributed in the body. The difficulties of cer-
tain forms of measurement of catabolism were alluded to, but it was pointed out that 
catabolism may be reliably measured under steady and non steady metabolic conditions 
by using urinary radioactivity and plasma specific activity data. 
The problem of measuring albumin synthesis under conditions of metabolic 
14 
change has been overcome by the use of the C carbonate method. Whereas on I y 
indirect information about synthesis could be gained from the use of iodine labelled 
tracers, the 14c carbonate method measures synthesis directly and independently of 
any catabolic measurements performed with iodinated preparations. The historical 
background and evolution, rationale, and assumptions of the method were described 
in detail. Recently certain modifications to the method have been suggested in 
order to achieve greater accuracy of measurement. Practical considerations pre-
cluded the implementation of some of these refinements, and the error associated 
with their deletion was assessed. The laboratory technique is described in outline 
in Chapter 3, whilst full details are provided in the Appendix. The chapter was 
concluded with a brief account of the various techniques of measuring albumin syn-
thesis indirectly with iodinated albumin preparations. 
The first part of Chapter 3 contained a description of the materials and 
methods employed in the thesis. For those methods fully described in the Appendix, 
only a general description was provided in th is chapter, but full detai Is were pre-
sented of all remaining methods. The second part of this chapter explained the 
experimental protocol and also discussed the factors which influenced the choice 
of this particular experimental design. Albumin metabolism was studied in three 
groups of rats. Changes in albumin synthesis and catabolism were measured in a 
group of hypophysectomised rats, in a group of hypophysectomised rats receiving 
daily injections of growth hormone, and in a control group pair fed to the hypophy-
sectom ised rats / •....... 
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sectomised rats and subjected to a sham operation. Measurements were carded out 
for nine days after hypophysectomy or sham operation. 
Chapter 4 set out the results of these experiments. The amount of food 
consumed by the hypophysectomised rats was measured and confirmed the well-known 
fact that this animals food intake is markedly reduced. G:eowth hormone adminir 
tration had no significant effect on this anorexia. Values of albumin synthesis and 
catabol ism in the normal control rats were then presented and compared with values 
obtained by other workers. In general, satisfactory agreement was demonstrat·ed. 
In the hypophysectomised rats eating ad libitum synthesis rates were signifi-
cantly reduced forty-eight hours after the operation, and were further reduced when 
measured seven days later. Catabol ism however showed a rise above normal levels 
forty-eight hours after the operation but then fell to abnormally low values. This 
fall occurred some three or four days later than the fall in synthesis rate. 
The sham operated rats which were pair fed to the hypophysectomised rats 
also showed a marked reduction in synthesis rates forty-eight hours post-operatively ff 
and the values obtained in th is group were not significantly different from the values 
observed in the hypophysectomised rats. However, when provided with more food 
at the end of the study period, the sham operated rats began to synthesise albumin 
at normal rates whereas synthesis in the hypophysectomised rats became further re-
duced. The post-operative rise in catabolism was much greater in the sham operated 
rats than in the hypophysectomised rats 1 and unlike the latter did not fall to sub~ 
normal levels. 
The synthesis rate when growth hormone was administered to hypophysectomised 
rats was at all times significantly greater than the synthesis rate in the untreated rats. 
It was observed that the synthesis rate fell progressively during the nine day study 
period so that whereas half the fractional values fell within the normal range two days 
after hypophysectomy, al I values were below normal at the end of the study period. 
These rats behaved similarly to the untreated hypophysectomised rats insofar as the 
synthesis rates fell progressivelydespite the increase in food consumption. The post-
operative increase in catabolism was significantly less than that of the sham operated 
rats, / ..... " . o ••••• " ••• 
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rats, being of the same magnitude as the untreated hypophysectomised rats. There-
after catabolism was observed to fal I to subnormal levels seven or eight days after 
hypophysectomy, some two to three days later than the time when this fall had al-
ready occurred in the untreated rats. Growth hormone wos thus observed to in-
crease both synthesis and catabolic rates. 
In Chapter 5, the results of the experiments were discussed and explained. 
The pair fed data was dealt with first and was compared with data obtained by other 
workers. It was confirmed that the regulation of albumin synthesis was intimately 
related to the availability of substrate amino acids, whereas catabolism appeared to 
proceed as a first order process based on the size of the intravascular albumin pool. 
The basis of the hypercatabol ic post-operative response was discussed and it was 
concluded that at least part of th is response was mediated by the pituitary gland, 
and was most likely to be due to excess A.C.T.H. secretion. 
From the data obtained, it was concluded that the early reduction in syn-
thesis rate after hypophysectomy was no greater than could be accounted for by a 
reduction in food intake. Later measurements however clearly indicated that 
hypopituitarism was contributing to the reduction in synthesis rate. The fall in 
catabolism was ascribed to a reduction in the intravascular albumin mass, although 
it could not be stated with certainty that falling hormonal levels were not contribu-
tory. From a consideration of the sham operation and hypophysectomy data together, 
it was concluded that part of the adaptations that occur in albumin metabolism 
during changes in dietary protein intake were mediated by the pituitary gland. 
Growth hormone was shown to increase the rate of albumin synthesis. Rates 
of synthesis however fell below the normal range and it was concluded that the poor 
food intake was one limiting factor. It appeared likely that glucocorticoid and thy-
roid hormones are necessary for normal albumin synthesis and that their absence also 
prevented the restoration of normal synthesis rate levels. The fall in catabolism was 
more confidently ascribed to a shrinking intravascular albumin mass than was possible 
for the untreated hypophysectomised rats. 
The mode of / .............. . 
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The mode of action of growth hormone was then discussed and it was pro-
proposed that the action of this hormone is to stimulate albumin synthesis, while 
any effects on catabolism are indirectly achieved through alterations in the intra-
vascular albumin mass. The concept was extended to include all albumin anabolic 
hormones and it was speculated that in health at least, albumin synthesis was hor-
monally controlled whereas catabolism was controlled by the intravascular pool 
size. Experiments undertaken to prove this were however unsuccessful. 
(1 ) 
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APPENDIX 
I. STATISTICAL METHODS 
Mean. X = 
Standard deviation of the mean. 
Standard error of the mean. e 
LX 
n 
s 
= 
= Jt= (x - x) 2 
n - l 
s 
(2) Linear regression analysis (Method of Least Mean Squares) 
The least square line approximating the set of points Q<l y1) (x2 , y2) I 
.••..••...•• (x , y ), is given by the equation y = mx + c where n n 
= NL xy -
m 2 
(rx) (1: y) 
2 
2 
and C = (c y) (ex ) - (ex) (I:xy) 
NI:x 
2 
- ('r::.xl NL X - (I: x) 
(3) Testing whether two independent groups have been drawn from the same 
population. 
For the numerous comparisons undertaken between the various sets of experi-
mental data the "significance of the difference" was tested by means of the Mann-
Whitney 1U1 test. This non-parametric test is an excellent alternative to the para-
metric Students' 1t 1 test, since no assumptions are made about either the distribution 
or the variances of the populations from which the samples are drawn. 
n (n 1 + l) U = n n2 + l 
~~.) l ~~2~~ 
- Rl -------------------- (1) 
or equivalently, U = n n
2 
+ n2 (n2 + 1) - R 
(obs.) 1 2 2 
------------------ (2) 
where R1 = sum of the ranks assigned to the group whose size is n1 
R2 = sum of the ranks assigned to the group whose size is n2 
and where n2 ) n1 
Where formulae (1) and (2) yield different values for 1 U1 select the smaller of the two. 
Whan, h,..+1,., I 
- 85-
When both n1 and n2 lie between 3 and 8, the exact probability (p) 
associated with the occurrence under Ho of any U as extreme as an observed 
U(U obs) may be determined. When n2 lies between 9 and 20 exact probabilities 
cannot be determined. In this instance critical values of U are provided from 
tables at different significance levels. Where U (obs) is less than or equal to 
the critical value of U, Ho may be rejected at the level of significance chosen 
i.e. the difference between the two groups is significant at that level. 
Wherever possible in the presentation of the data, exact probabilities have 
been provided. Where sample sizes precluded this the observed value for U is 
presented together with the critical value of U at the .001 and .01 significance 
levels. 
For example: U(obs) = 8. From tables: Critical value of U at the • 001 level = 4 
Critical value of U at the . 01 level = 12 
Then the two groups that were compared are significantly different at the .01 level, 
but not at the • 001 level since 8 is less than 12 but greater than 4. In presenting 
values of Uthe following convention (as illustrated by the figures in the above 
4 
example) was employed: (8 12) 
Significance was assessed at the following levels:-
p < · .05 Probably significant 
-
p < • 01 Significant 
-
p < .001 Highly significant 
II SPECIFICATIONS FOR GROWTH HORMONE, BOVINE, NIH-GH-814 
(as provided by the National Institutes of Health) 
GROWTH HORMONE ACTIVITY: 
Growth hormone activity was determined by the ten day body weight gain 
test in 100 gm. hypophysectomised female rats (1), using the subcutaneous injection 
modification (2) / •........• 
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modification (2). USP Growth hormone was used as the reference preparation. 
The unweighted geometric mean potency of N IH-GH-Bl 4, obtained from five 
replicate assays, was 1 .04 USP units per mg. 
CONTAMINATION WITH OTHER PITUITARY HORMONES: 
THYROID STIMULATING HORMONE (TSH) ACTIVITY: TSH Activity was 
determined by the P-32 uptake method using baby chicks (3). USP TSH was used 
as the reference preparation. The unweighted geometric mean potency obtained 
from two assays was 0.0021 USP units/mg. 
LUTEINISING HORMONE (LH) ACTIVITY: LH Activity was determined by 
the ovarian ascorbic acid depletion assay (4) (7) NIH-LH-Sl was used as the reference 
preparation. The unweighted geometric mean potency obtained from two assays was 
0.0017 NIH-LH-Sl units/mg. (One unit= activity in one mg. of NIH-LH-Sl .) 
FOLLICLE STIMULATING (FSH) HORMONE ACTIVITY: FSH Activity was 
determined by the HCG-augmentation method (5). NIH-FSH-Sl was used as the 
reference preparation. A total dose of 7200 micrograms of N IH-GH-Bl 4 failed to 
elicit a significant response. Therefore, this preparation is judged to contain a 
maximum of 0.0097 NIH-FSH-Sl units/mg. (One unit= activity in one mg. of 
N IH-FSH-Sl • ) 
PRO LACTIN ACTIVITY: Prolactin activity was determined by the pigeon crop-
sac weight method (6). The results are expressed in terms of the 2nd International 
Standard for Prolactin. A total dose of 12 mg. failed to elicit a significant re-
sponse in this assay. Therefore, NIH-GH-B14 is judged to contain a maximum 
of 0.42 I. U/mg. prolactin activity. 
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Ill METHODS 
A Hypophysectomy: 
Provided the colony from which the rats were drawn had received the cus-
tomary attention to feeding and hygiene, no special pre-operative measures were 
found to be necessary. On the morning of the operation food and water was with-
held in order to prevent regurgitation under anaesthesia. The rat was placed in 
a bell jar and anaesthesia induced with Halothane at a concentration of 3.5%, 
oxygen being provided at a flow rate of four litres per minute. Induction was 
rapid and uniformly satisfactory. 
Once anaesthesia had been induced the area for inc is ion was shaved and 
the rat returned to the bell jar. At th is stage the Halothane was reduced to a 
concentration of l % and gauze swabs moistened with ether were introduced into 
the bell jar in order to deepen the level of anaesthesia. Using the pattern of 
respiration as a guide to the level of anaesthesia, when the plane of surgical 
anaesthesia was reached, the rat was removed from the bell jar and placed on an 
operating board on its back with its head towards the operator, and immobilised 
in this position by means of rubber bands looped about the legs. The head and 
neck were extended by a firm rubber band passed over the upper incisors. Anaes-
thesia was maintained by ether swabs placed near the mouth and nostrils of the rat. 
A skin incision was placed in the midline of the neck extending for two to 
three centimetres caudad to the mandibular papilla and the underlying salivary glands 
and lymph nodes separated in the mid line by blunt dissection. The sternohyoid mus-
cles were then split in the mid line to expose the trachea in preparation for the in-
sertion of a tracheostomy, (photograph l) for in gaining adequate exposure of the 
site for drilling/ ......... .. 
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site for drilling, the respiratory passages are completely blocked and respiration is 
impossible unless a tracheostomy is provided. The closed tip of a fine pair of for-
ceps was passed through the right omohyoid muscle near its posterior border, and 
then opened in order to split the muscle longitudinally for one and a half to two 
centimetres. The forceps was then passed behind the oesophagus and was pushed 
through the left omohyoid muscle. The surgical plane for the placing of a staying 
suture (see fol lowing paragraph) was conveniently defined by al lowing the forceps 
to remain in this position while the tracheostomy tube was inserted. 
A sharp pointed scalpel blade was used to incise the trachea, (photograph 2). 
In order to prevent bleeding the space between the two cartilagenous rings with the 
least number of visible capillaries was chosen for incision. A small len9th of soft 
plastic tubing (infant nasal feeding tube, size 5 French was found to be suitable) 
was inserted (photograph 3) and secured in place by a staying suture passed not only 
around the trachea, but also encompassing the strap muscles, and the oesophagus. 
Once the staying suture was tied anteriorly the forceps which had assisted in its 
positioning was removed. Since the oesophagus, trachea and strap mu6cles were 
contained within a single suture, they were conveniently retracted laterally to the 
left by means of a single retractor, thereby exposing the prevertebral muscles {longus 
col Ii) and the base of the skull. (photograph 4). lv\ore favourable exposure was 
obtained by the use of additional retractors to draw the sternomastoid muscles of each 
side laterally. 
Photograph 1 / •............ 
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Photograph l 
The sternohyoid muscles have been split in the midline and retracted 
laterally to expose the trachea. The thyroid gland is clearly visible at the 
proximal end of the trachea. 
Photograph 2 
Tracheotomy is performed by means of a sharp pointed scalpel blade. 
The trachea over I ies and partial! y obscures the pair of forceps used to define 
the surgical plane of a staying suture. 
Photograph 3 
The tracheostomy tube is shown in. posi tion. The submandibular sal ivary 
gland and a lymph node are visible to the right of the trachea. 
Photograph 4 
The trachea, oesophagus and strap muscles have been retracted laterally 
to the left. Addltional lateral retractors have drawn the sternomastoid muscles 
aside, and a curved forceps has been used to retract the free border of the anterior 
digastric muscles in a cephalad d irection. The muscles visible in the centre of 
the operating field are the longus colli which overl ie the basi-occiput. The two 
muscles can be seen to be separated by a fibrous membrane which has attachments 
to the basi-occiput, and to the posterior pharyngeal wall (the latter attachment 
not visible in this photograph). The spheno-occipital synchondrosis can be seen 
as a faint line deep to longus col Ii muscles near their apex (between the blades of 
the curved forceps in th is photograph). 
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From this point on I the operation was carried out with the help of an 
operating microscope, and a good source of ii lumination. A magnification 
factor of six was found to be most suitable. This author was fortunate enough 
to have the use of an instrument which projected the source of I ight through 
the magnifying lens. Presumably equally satisfactory results would be obtained 
with less sophisticated apparatus. 
A small curved forceps was introduced against the free border of the 
anterior belly of the digastric muscles, and moderate traction cephaled exposed 
the area to be drilled (photograph 4). The posterior wall of the pharynx, lying 
just deep to the digastric muscles, became visible along its entire attachment to 
the base of the skull, and the firm fibrous band running from it to the preverte-
bra I muse I es was cut (photograph 5). The fact that the pharyngea I insertion is 
linear has considerable bearing on the subsequent steps to be taken in the operation, 
as will be outlined below. The longus colli muscles gain a fiat insertion on the 
basi-occiput and terminate in juxaposition to the pharynx at the spheno-occipital 
synchondrosis. This synchondrosis provides the landmark for placing the drill bit. 
The linear attachment of the pharynx lies directly over the intracranial 
site of the pituitary gland and access may therefore be gained by drilling on 
either side of the pharyngeal wall, i.e. from either within the nasal cavity, or 
from without, viz. from the neck. The main departure here from the method used 
by Smith, (l 2) is in respect of the approach to the pituitary gland. That author 
incised the pharyngeal wall and gained access to the gland through the roof of the 
nasal cavity. The method used here leaves the pharynx intact by approaching the 
gland from the neck. Experience has shown that if the linear attachment of the 
pharynx is disturbed, and artificial opening is created between the nasopharynx 
and the neck muscles through which the animal breathes once the tracheotomy 
is closed. This leads to intense respiratory difficulties, and a fatal outcome 
within a few hours is invariable. Therefore when scraping away the longus colli 
muscle from its attachment to the occiput, a small fringe of this muscle was left 
intact to act as a reinforcement to the pharyngeal insertion (photograph 6 and 7). 
Photograph 5 / •......•..•• 
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. Photograph 5 
The fibrous band running between the posterior pharyngeal wall and the 
base of the skull is cut. 
Photograph 6 
The longus colli muscles are scraped off the base of the skull, with·a den tal 
periosti um elevator. The right longus colli muscle h.as been stripped of it's attach-
ment, and the left longus colli is in the process of being stripped. 
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Once the muscle overlying the synchondrosis had been scraped free, an 
electric dental drill operated by a foot pedal was used to drill the base of the 
skull (photograph 7). An angled handpiece and a No. 6 round headed ash bur 
was found to be most suitable for the size of the rat used in this work. The drill 
was placed vertically over the synchondrosis, and a vertical direction of dril I ing 
maintained throughout the thickness of the skull base. Since the synchondrosis 
is not itself vertical but slopes somewhat; maintaining a vertical path in drilling 
will ensure that the drill bit comes to be completely cephalad to the synchondrosis. 
The complete thickness of the skull may be drilled, or the innermost table of bone 
picked clear with a dissecting needle. If the former method is chosen, care must 
be taken to determine if both lobes of the gland have not been pushed to one side 
of the hole by the rotating action of the drill bit. Failure to do so may result in 
incomplete aspiration of the gland. 
A finely drawn out glass pipette was inserted into the hole and the gland 
aspirated by means of a mechanical aspirator (photographs 8, 9 and 10). The 
three lobes of the gland were always identified inside the glass pipette. By 
adopting this procedure, a complete hypophysectomy was assured since experience 
had shown that the lobes never fragment. 
Debris was cleared away and the retractors removed. The tracheostomy 
tube was removed and any mucous and blood that had accumulated in the tra~hea 
was gently aspirated. The tracheotomy was closed with a single silk suture (5'Q1 
on an atraumatic round bodied needle). Skin closure was obtained with three or 
four small surgical clips or silk sutures. 
Recovery from the anaesthetic was usually complete within ten to fifteen 
minutes after completion of the operation. The cages were kept dry by frequent 
changes of newspaper bedding and drinking water was generously provided. 
In the rat the absence of any firm attachment of the gland to its sheath, 
and the presence of a strong diaphragma sellae, prevent any damage to the hypo-
thalamus when the gland is aspirated. The rat exhibits only a temporary diuresis 
for one to two days since the pituitary stalk becomes revascularised and neuro-
hypophyseal function returns. Once experience had been gained, the operation 
not lasting longer than ten minutes, a survival rate of approximately 60% was achieved. 
Photograph 7 / • , , , , · • • , • . 
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Photograph 7 
The base of the skull is drilled at the position of the spheno-occipital 
synchondrosis which is seen as a faint line running across the drill hole. The 
cushioning rim of longus colli muscle in juxtaposition to the pharyngeal wall is 
clearly seen. 
- Photographs 8 - 10 
Aspiration of the pituitary gland into the glass pipette. 
' -. ~ 
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Photograph 9 
Photograph l 0 
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. Photograph 11 
After removal of the pituitary gland the base of the bra in and some 
of the blood vessels comprising the Circle of Willis, are clearly visible. 
Photograph 12 
A composite view of the operating field. The size .of the pituitary 
gland may be compared with that of the head of a matchstick. 
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B Preparation of Rat Albumin 
(a) To one volume of plasma add two volumes of normal saline. 
(b) Add three volumes of ammonium sulphate saturated at 37° dropwise 
with continuous shaking. 
(c) Al low to stand for thirty minutes, and then centrifuge to remove 
globulin precipitate. 
(d) Bring supernatant to pH 4.6 with l 0% (v/v) acetic acid. 
(e) Allow to stand for ten minutes. Centrifuge. 
(f) Dissolve albumin precipitate in distilled water. Bring to pH 7.0 
with 0.1 N sodium hydroxide. 
(g) To remove residual salt, dialyse overnight against distilled water 
0 
at 4 • 
(h) Fina II y check (i) concentration of albumin by biuret method 
(ii) purity of fraction by cellulose acetate electro-, 
phoresis. 
C Determination of Plasma Albumin Concentration 
Note. In this thesis, the original method as described hereunder was scaled 
down for use on half volumes of plasma. 
Reagents 
l. O. 9% (w/v) NaCl. 
2. HCl - ethanol. 
To 600 ml. of 11denatured 11 ethanol add l .O ml. concentrated HCl 
(Denatured ethanol is a mixture of 95% absolute ethanol and 5% 
methanol). Store at 4°. 
3. 0.2M Sodium acetate-ethanol. 
Dissolve 2.7218 mg. sodium acetate in 5.0 ml. methanol. Add 
95.0 ml. absolute alcohol. 0 Store at 4 • 
Note. Sodium acetate is soluble in methanol but not in absolute ethanol. 
Solution must therefore be achieved in methanol prior to the addition of 
ethanol. 
4. 3% / .......... . 
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4. 3% (w/v) Sodium hydroxide. 
5. Biuret reagent. 
Dissolve (i) 17.3 g. Copper sulphate pentahydrate in 100 ml. hot 
distilled water. 
(ii) 173 g. Sodium citrate and l 00 g. anhydrous sodium car-
bonate in 800 ml. distilled water while heating. 
When cool, pour (ii) into (i) with rapid stirring. Dilute to one 
litre with distilled water. 
6. Protein standard. 
Method 
(a) 
(b) 
(c) 
(d) 
(e) 
(f) 
(g) 
(h) 
(i) 
(j) 
30 mg/ml. aqueous solution of crystal! ine bovine albumin. 
To 0.2 ml. of plasma add 0.8 ml. of normal saline. 
Add 9 .0 ml. HCl-ethanol dropwise with continuous shaking. 
Incubate for thirty minutes at 37°. 
Centrifuge. 
Transfer 5.0 ml. of the albumin rich supernatatant fluid to another 
centrifuge tube. 
Add 0.5 ml. 0.2M sodium acetate-ethanol dropwise with continuous 
shaking. 
Stopper and allow to stand at room temperature for ten minutes. 
Centrifuge. Tip off supernatant. Invert tubes on filter paper to 
ensure all supernatant fluid is removed. 
Dissolve precipitate in 5.0 ml. 3% sodium hydroxide, add 1.0 ml. 
biuret reagent, and mix by inversion. 
Read intensity of colour produced after thirty minutes at 545 JJ· 
A reagent blank consists of 5.0 ml. 3% sodium hydroxide plus 1.0 ml. Biuret 
reagent. The known protein standard is made to consist of 4. 9 ml. 3% sodium hy-
droxide, 0.1 ml. of a 3g. % bovine albumin solution, and l .O ml Biuret reagent. 
Colour production was measured on a Zeis PMQI I spectrophotometer. 
D Iodination/ •••••••••• 
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D Iodination 
Reagents 
l. Approximately 15 mg. of ammonium sulphate prepared albumin is used for 
labelling. This should be contained in a volume no greater than 0.5 ml. 
2. Iodine monochloride (stock solution). 
(i) Dissolve 150 mg. sodium iodide in 8.0 ml. 6N HCl. 
(ii) Dissolve 108 mg. sodium iodate monohydrate in 2.0 ml. distilled 
water. 
(iii) Forcibly inject (ii) into (i) to avoid precipitation of iodine. 
(iv) Dilute to 40.0 ml. with distilled water and shake with 5.0 ml. 
carbon tetrachloride. 
The presence of a red discolouration in the organic solvent indicates the 
presence of free iodide. The carbon tetrachloride is removed with a pipette, and 
the extraction process is repeated until the carbon tetrachloride remains unchanged 
in colour. 
(v) Bubble moist air through !Cl solution for one hour to remove any re-
sidual carbon tetrachloride. 
(vi) Make up to 45.0 ml. with distilled water. This stock !Cl solution 
is stored at 4°C. 
(vii) Before use, dilute one volume of stock solution with nine volumes 
of 2M NaCl. 
3. Glycine buffer (stock solution). 
(i) Dissolve 7.5 g. glycine in 75.0 ml. distilled water. 
(ii) Add 25. 0 ml. l N NaCl • 
Alkaline glycine buffer (pH 9. 0 - 9. 5) is made up prior to use by the addition 
of 0.2 ml. lN (w/v) NaOH to 1.8 ml. of the stock solution. 
Method 
(a) Prepare alkaline glycine buffer as above. 
(b) Prepare / •.. , •.••••• , . 
E. 
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(b) Prepare 1 .0 ml. of a working solution of ICl. (0.1 ml. ICl plus 
0.9 ml. 2M NaCl). 
(c) Place required amount of radio iodine solution in 0.3 ml. working 
ICl solution. (Tube A). 
(d) Bring pH of albumin solution to 8 .5 with alkaline glycine buffer. 
(Tube B). 
(e) Likewise bring pH of Tube A to 8.5. 
(f) Rapidly inject contents of tube A into tube B by means of a Pasteur 
pipette. 
Note: Once the pH of Tube A reaches 8.5, side reactions, in which radio-
iodine participates, are initiated. The radioiodine thus involved becomes 
unavailable for protein labelling. (72) Therefore to ensure maximum 
efficiency of iodination, as little delay as possible should occur between 
steps (e) and ( f). 
(g) If labelled albumin is to be used for synthesis rate studies, remove 
free iodide by passage through a five centimetre column of Deacidite 
FF resin in the chloride form. 
(h) If labelled albumin is to be used for catabolic rate studies, add 1.0 ml. 
of fresh rat plasma and carry out ammonium sulphate precipitation and 
dialysis against distilled water. 
(i) In either case check free radioiodide content on a small aliquot (0.01 ml.) 
of the final preparation by trichloroacetic acid precipitation. 
(j) Subject final preparation to eel lulose acetate electrophoresis, and as-
certain that the label is confined only to the albumin fraction. 
(k) Sterilise by "millipore" filtration prior to use. 
Measurement of Albumin Synthesis 
Reagents: 
l • l 0% (w/v) and 5% (w/v) trichloroacetic acid. 
2. Absolute ethanol. 
3. CO 2 free 1 N NaOH. 
(i) Prepare CO2 free water by boiling 200 ml. distilled water to half its 
volume. 
(ii) To 1 0. 0 m I / ••.......• 
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(ii) To 10.0 ml. of lON NaOH (In which CO2 is insoluble) add 90 ml. 
CO
2 
free H20. Stopper tightly and prepare a fresh solution for 
each batch of samples processed. 
4. 4MCitricacid. 
5. Phosphate buffer (pH 6- 7). 
Dissolve 41 .75 g. sodium pyrophosphate and 5.7 ml. orthophosphoric 
acid in 500 m I. d isti 11 ed water. 
6. Urease so I ution. 
A 1 mg/ml. solution of urease (Nutritional Biochemicals Corporation, 
Cleveland, Ohio, U.S.A.) in phosphate buffer. Stored at 4° and 
renewed men th I y. 
7. 10% (w/v) Sodium tungstate. 
8. Tungsticacid. 
Make up 10.0 ml. 10% (w/v) sodium tungstate and 3 .8 ml. 1 N HCl 
to 100 ml. with distilled water. 
9. Citric-tungstic acid solution. 
A 1 : 1 mixture of 4M citric acid and tungstic acid. 
10. 0.66 N Sulphuric acid. 
11. Resins: (Deacidite FF resin is obtained commercially in the chloride form). 
A. 
(i) 
(ii) 
(iii) 
(iv) 
Hydroxide form. 
Wash the chloride form with distilled water until eluate is clear. 
Wash with 2 - 3 I itres of 4N NaOH. 
Wash with 2 - 3 litres of 2N NaOH. 
Determine if eluate is free of chloride ions by testing with silver 
nitrate at acid pH. 
(v) If necessary repeat washings with 4N and 2N NaOH until eluate is 
(vi) 
B. 
(i) 
(ii) 
C. 
chloride free. 
Wash with distilled water to pH 7. O. 
Carbonate Form 
Wash the hydroxide form with several litres of 0.5N sodium bicarbonate. 
Wash with distilled water to pH 7.0. 
Mixed form. 
A 1 : 1 mixture of chloride and hydroxide forms. 
12. Activated/ •.....•.... 
= l 02 ~ 
12. Activated arginase solution. 
Prepare manganese/maleic buffer. 
(i) Dissolve 8. 90 g. sodium maleate in 200 ml. distilled water. 
(ii) Bring pH to 9.7- 9.8 with l N NaOH. 
(iii) Add 11 .5 g. Manganese sulphate (MnS04.4H20) and make up to 
500 ml. with distil led water. 
(iv) Bring to pH 7. 0 wit'h l N HCl . 
Arginase solution is made up as a l mg/ml. solution of arginase (Nutritional Bio-
chemicals Corporation) in manganese/maleic buffer. 
Add required amount of arginase to the appropriate volume of buffer, and 
incubate for three hours at 37°. The solution is stored at 4° and renewed 
every two months. 
13. Phenylethylamine-methanol. 
(i) RedistH commercially obtained phenylethylamine until yellow colour 
is removed. 
("") !I Mix with an equal volume of methanol. 
(iii) Store in a dark bottle in a lightproof cupboard. 
14. Scintillation mixture. 
Dissolve 7.5 g. 2y5-diphenyloxazole (P.P.O.) and 0.75 g. 
l ,4-bis-(4=methyl-5-phenyloxazole-2-yl) benzene (P.O.P.O.P.) 
in 2.5 litres anhydrous toluene. 
METHOD 
A. Preparation of samples for measurement of albumin guanidine carbon S.A. 
l • Extraction of albumin from plasma 
(i) Pool 0.25 ml. plasma from each of the four rats in the batch being 
studied. To this add 1.0 ml. of a 100 mg/ml. aqueous solution of 
crystal I ine bovine albumin. 
(H) Add 2.0 ml. cold 10% trichloroacetic acid. 
(iii) Mix wel I, centrifuge and discard supernatant. 
(iv) Wash/ •........•.. 
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(iv) Wash precipitate with 2.0 ml. cold 5% trichloroacetic acid. 
Centrifuge and discard supernatant. 
(v) Add 6.0 ml. absolute ethanol to precipitate. Mix thoroughly and 
centrifuge to remove globulin precipitate. 
(vi) Dialyse albumin rich supernatant against distilled water overnight 
0 
at 4 • 
(vii) Concentrate sample to approximately 2 ml. Confirm homogenecity 
of fraction by cellulose acetate electrophoresis. Measure the 
volume and concentration by Biuret method to give the total amount 
of albumin present. 
II Acid ~f1roJ.Yyis of albumin 
(i) Given that 100 ml. of 6N HCl is added to 250 mg. protein¥ 
determine amount of 6N HCl required for sample (I vii). 
(ii) Add volumes of water and concentrated HCl to sample (making 
allowance for the volume of the sample itself) such that the 
final solution is 6N with respect to HCl. 
(iii) Transfer to hydrolysis tubes and hydrolyse for 16 hours at 110- 115°. 
(iv) Transfer hydrolysate to round-bottom flask and evaporate to dryness. 
(v) Wash with 3 to 5 ml. distilled water and evaporate to dryness. 
(i) Dissolve amino acid residue in 2 to 3 ml. distilled water. 
(ii) Bring to pH 7. 0 by the addition of Deacidite FF resin in the 
carbonate form. 
(iii) Pass through a sintered glass column containing approximately 5 mm. 
of the carbonate resin as a filter bed. 
(iv) Wash flask with about 10 ml. distilled water and add washings to 
the column. 
(v) Collect eluate in round bottom flask. 
If less than 100 mg. albumin was hydrolysed:-
(a) Add 2 ml. activated arginase solution. 
(b) Bring to pH 9.0 with 1 N NaOH. 
(c) Incubate/ •......•.• 
B. 
(c) 
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0 Incubate for 16 hours at 38 • 
If more than 100 mg. albumin was hydrolysed:-
(a) Prepare a column (9 by l cm.) of mixed chloride 
and hydroxide resins. Wash with distilled water 
to pH 7.0. 
(b) Concentrate eluate (II I v) to approximately 2 ml. 
and place on column. 
(c) Wash column with distilled water, collecting 4 ml. 
aliquots of the eluate. Collect six such aliquots. 
(d) Spot one drop of each aliquot on filter paper and dry 
in a hot oven (~ 11 0°), Spray with n inhydrin and 
return to oven until dry. The presence of arginine 
is indicated by the spot turning a purple colour. 
(e) Place those aliquots containing arginine into a round 
bottom flask, add 3 ml, activated arginase solution, 
adjust to pH 9.0 and incubate as above. 
After incubation 
(vi) Bring sample to pH 2. 0 with 4 M citric acid. 
(vii) Evaporate to dryness. 
(viii) Dissolve urea solution in l ml. distilled water and 0.5 ml. 
phosphate buffer. Bring to pH 7.0 with CO 2 free l N NaOH. 
Sample is now ready for gas- train, (Figure A: l) 
Preparation of samp I es for measurement of urea carbon S. A. 
(i) Pool 0. l ml. blood from each of the four rats in the batch being 
studied. Add 2.0 ml. of al mg/ml. aqueous solution of urea. 
(ii) Precipitate proteins by adding l. 0 ml. l 0% sodium tungstate, 
and 1.0 ml •• 66N sulphuric acid. Mix well and centrifuge. 
(iii) Place protein free supernatant in round bottom flask and 
evaporate to dryness. 
(iv) Redissolve in l .0 ml. distilled water and 0.5 ml. phosphate 
buffer. 
(v) Bring to/ ......... 
C 
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(v) Bring to pH 7.0 with CO2 free 1 N NoOH. 
Sample is now ready for gos-train. (Figure A: 1) 
14 Measurement of CO 2 S.A. 
(i) Place sample in centre bulb of reaction vessel. Place 1 ml. 
ureose in one side-arm and 1 ml. citric .. tungstic acid solution 
in the other side-arm. 
(ii) Briefly immerse vessel in a solid CO2-ethanol mixture and 
evacuate gasses present in solution during gentle thawing. 
Seal vessel by closing top. 
(iii) Tip in ureose from side-arm and allow to incubate for one hour 
at room temperature. 
(iv) At the end of this time tip in the acid mixture and shake gently 
to release enzymatically produced CO2 . 
(v) Place reaction vessel on gas-train and immerse in sol id C02-
ethanol. 
(vi) Evacuate gos line. 
(vii) Immerse cold finger in liquid nitrogen and allow CO2 to poss 
from reaction-vessel to cold finger. 
(viii) Evacuate any contaminant gasses present whilst CO2 sample is 
trapped under I iquid nitrogen in the cold finger. 
(ix) Close top above cold finger. Thaw cold finger in worm water 
and then immerse in solid CO2 - ethanol, thus releasing the CO2 
sample but trapping any contaminant gasses. 
(x) Fill cuff surrounding manometer arm with liquid nitrogen and 
allow CO2 sample to pass from cold finger to manometer arm 
by opening the intervening taps. 
(xi) Raise mercury column to trap CO2 sample in the manometer arm 
and thaw by adding worm water to the cuff. The CO2 sample is 
thus released into the modified Moc Leod chamber. 
Figure A: 1 
Cb) 
Pirani gauge 
tp 
~,~ 
(e) 
1 
Vacuum 
The high vacuum gastrain. The reaction vessel (a) is shown 
in position on the gastrain. The CO2 sample is initially 
transferred to the cold finger (b) and thence to the modified 
Macleod chamber (d) by means of the liquid nitrogen cuff (c). 
After measuring its volume the sample of CO2 is transferred 
to and trapped in the phenylethylamine-methanol mixture (e). 
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(xii) Raise mercury column to the reference mark on the modified Macleod 
chamber and determine the scale reading indicated by the height of 
the mercury column in the manometer side-arm. 
(xiii) Lower mercury column and transfer CO 2 sample to the tube containing 
2 ml. of the phenylethylamine-methanol mixture frozen under liquid 
nitrogen. 
(xiv) Remove tube and after thawing transfer solution to a counting vial 
containing 8 ml. of the P.P.0.- P.O.P.O.P. scintillation mixture. 
D Calculation of Albumin Synthesis Rate. 
(i) Convert volumes of CO 2 into mg. C by means of previously constructed 
calibration graphs for known amounts of urea. 
(ii) Calculate S. A. (expressed as counts per minute per mg. C) for each of 
urea samples. 
(iii) Correct these S. A. measurements for the 2 mg. of stab le urea added. 
(iv) Plot corrected S. A. measurements on log- I in ear graph paper, 
(Figure A: 2). 
(v) By least mean squares method plot the best fitting I ine through these 
points. 
(vi) Extrapolate line back to 1y 1 axis and determine urea S.A. at t 
0 • 
(vii) From graph determine rate of fall of urea S.A. per hour i.e. 
fractional S.R. of urea per hour. 
11. Albumin guan idine carbon S, A. measurement 
(i) Calculate albumin S.A. as in I (i) and (ii) above. 
(ii) Correct the S,A, measurement for the l 00 mg. bovine albumin added. 
(iii) Determine albumin S. A. t0 by multiplying the observed S. A. at t6 by 
the factor derived from the disappearance of the iodinated albumin 
sample over the six hour experimental period. 
Then/ ••...•...........•.. 
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Then, 
Fractional S. R. albumin 
(% I. V. P. / hour) 
and 
Absolute S. R. albumin 
(mg./ hour) = 
= fractional S. R. urea/hour x albumin S .A. t0 
urea S.A. t0 
Fractional S. R. albumin x intravascular 
albumin pool. 
WORKED EXAMPLE OF SYNTHESlS RATE CALCULATION 
Heightof 
Hrs mercury C column mg. • C P M 
S.A. 
••. (C.P.M./mg.C) 
Corrected. S .A. 
(C. P. M./mg .C) 
(cm.) 
3.0 20.2 0.24904 6927. 9 27,818 
3.5 20.5 0.25315 6740.5 26,627 Plasma urea= 67 mg/ 
4.0 21.0 0.26000 6588.9 25,342 l 00 ml. 
4.5 20.4 0.25178 6119.9 24,307 Stable urea added 
5.0 21.4 0.26548 5991.4 22,568 = 2. l O mg. 
5.5 19 .5 0.23945 5038.4 21.042 therefore correction 
6.0 20.3 0.25041 5054.6 20,185 factor is 8.83 
From graph corrected urea S.A. t = 346,300 
0 
F t . I S R (o,. /1.. ) (urea S. A. t0 - urea S. A. t1) x l 00 rec 1ona .. urea 101 ,,r = -------,---------
urea S.A. t 0 
= (346,300 310,020) X l 00 
346,300 
= l 0.48 
245,633 
235,116 
223,770 
214,631 
199,275 
185,801 
178,234 
Table/ •.................. 
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Height of S.A. 
mercury ( / ) Hrs. column mg.C. C.P.M. C.P.M. mg.C 
Corrected S. A. 
(C. P. M./mg.C) 
(cm.) 
i' 
6.0 14.5 0.17095 636.6 3,724 Plasma alb. = l .73g/ 25,249 
l 00 ml. 
Sam-
pies 
in 13.9 o. 16273 644. l 3,958 Stable alb. added = 26,835 
dupli- 100 mg I 
•cate therefore correction 
factor = 6. 78 
Mean corrected albumin S.A. t 6 = 26,042 c.p.m./mg.C. 
The 1251 activity of an 0.02 ml. aliquot of plasma was observed to fall to 49.8% 
of its original value over the experimental period of 6 hours. 
Therefore corrected albumin S.A. t 0 
Fractional S. R. albumin (% I. V. P ./hr) 
Plasma albumin concentration 
Plasma volume 
lntravascular albumin pool 
= 
= 
= 
Absolute S. R, albumin (mg/hour) 
= 
26,042 X l 00 
49,8 
= 52,293 c .p. m./mg, C 
= 
52,293 X l 0.48 
346,300 
l . 73 g/1 00 m I 
6.65 ml. 
115. 0 mg. 
= 1.58 X 115.0 
l 00 
= 
= 
1.8 
1.58 
Fractional and absolute synthesis rates were multiplied by 24 to give an average daily 
value. 
1,000 
500 
CORRECTED UREA 
S.A. 
( CPM/mgC x103) 
100 
0 
-.... -- --
-.... -.... -- --
3 4 5 6 
HOURS 
Figure A:2 Semi logarithmic plot of urea C plasma specific activities. 
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